<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39409138</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Proteomic Evidence for Amyloidogenic Cross-Seeding in Fibrinaloid Microclots.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10809</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms251910809</ELocationID><Abstract><AbstractText>In classical amyloidoses, amyloid fibres form through the nucleation and accretion of protein monomers, with protofibrils and fibrils exhibiting a cross-&#x3b2; motif of parallel or antiparallel &#x3b2;-sheets oriented perpendicular to the fibre direction. These protofibrils and fibrils can intertwine to form mature amyloid fibres. Similar phenomena can occur in blood from individuals with circulating inflammatory molecules (and also some originating from viruses and bacteria). Such pathological clotting can result in an anomalous amyloid form termed fibrinaloid microclots. Previous proteomic analyses of these microclots have shown the presence of non-fibrin(ogen) proteins, suggesting a more complex mechanism than simple entrapment. We thus provide evidence against such a simple entrapment model, noting that clot pores are too large and centrifugation would have removed weakly bound proteins. Instead, we explore whether co-aggregation into amyloid fibres may involve axial (multiple proteins within the same fibril), lateral (single-protein fibrils contributing to a fibre), or both types of integration. Our analysis of proteomic data from fibrinaloid microclots in different diseases shows no significant quantitative overlap with the normal plasma proteome and no correlation between plasma protein abundance and their presence in fibrinaloid microclots. Notably, abundant plasma proteins like &#x3b1;-2-macroglobulin, fibronectin, and transthyretin are absent from microclots, while less abundant proteins such as adiponectin, periostin, and von Willebrand factor are well represented. Using bioinformatic tools, including AmyloGram and AnuPP, we found that proteins entrapped in fibrinaloid microclots exhibit high amyloidogenic tendencies, suggesting their integration as cross-&#x3b2; elements into amyloid structures. This integration likely contributes to the microclots' resistance to proteolysis. Our findings underscore the role of cross-seeding in fibrinaloid microclot formation and highlight the need for further investigation into their structural properties and implications in thrombotic and amyloid diseases. These insights provide a foundation for developing novel diagnostic and therapeutic strategies targeting amyloidogenic cross-seeding in blood clotting disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kell</LastName><ForeName>Douglas B</ForeName><Initials>DB</Initials><Identifier Source="ORCID">0000-0001-5838-7963</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Crown St., Liverpool L69 7ZB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Novo Nordisk Foundation Centre for Biosustainability, Building 220, S&#xf8;ltofts Plads 200, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Private Bag X1 Matieland, Stellenbosch 7602, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pretorius</LastName><ForeName>Etheresia</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9108-2384</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Crown St., Liverpool L69 7ZB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Private Bag X1 Matieland, Stellenbosch 7602, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000682">Amyloid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9001-31-4</RegistryNumber><NameOfSubstance UI="D005337">Fibrin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020543">Proteome</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058227">Amyloidogenic Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="Y">Proteomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000682" MajorTopicYN="Y">Amyloid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000686" MajorTopicYN="N">Amyloidosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005337" MajorTopicYN="N">Fibrin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020543" MajorTopicYN="N">Proteome</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058227" MajorTopicYN="N">Amyloidogenic Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001777" MajorTopicYN="N">Blood Coagulation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyloid</Keyword><Keyword MajorTopicYN="N">clotting</Keyword><Keyword MajorTopicYN="N">cross-seeding</Keyword><Keyword MajorTopicYN="N">fibrils</Keyword><Keyword MajorTopicYN="N">fibrinaloid</Keyword><Keyword MajorTopicYN="N">proteomics</Keyword></KeywordList><CoiStatement>E.P. is a named inventor on a patent application covering the use of fluorescence methods for microclot detection in long COVID. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39409138</ArticleId><ArticleId IdType="pmc">PMC11476703</ArticleId><ArticleId IdType="doi">10.3390/ijms251910809</ArticleId><ArticleId IdType="pii">ijms251910809</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Meade T.W., Chakrabarti R., Haines A.P., North W.R., Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br. Med. J. 1979;1:153&#x2013;156. doi: 10.1136/bmj.1.6157.153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.1.6157.153</ArticleId><ArticleId IdType="pmc">PMC1597599</ArticleId><ArticleId IdType="pubmed">420998</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwell P.M., Howard S.C., Power D.A., Gutnikov S.A., Algra A., van Gijn J., Clark T.G., Murphy M.F., Warlow C.P. Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke. Stroke. 2004;35:2300&#x2013;2305. doi: 10.1161/01.STR.0000141701.36371.d1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.0000141701.36371.d1</ArticleId><ArticleId IdType="pubmed">15345800</ArticleId></ArticleIdList></Reference><Reference><Citation>Kattula S., Byrnes J.R., Wolberg A.S. Fibrinogen and Fibrin in Hemostasis and Thrombosis. Arterioscler. Thromb. Vasc. Biol. 2017;37:e13&#x2013;e21. doi: 10.1161/ATVBAHA.117.308564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.117.308564</ArticleId><ArticleId IdType="pmc">PMC5324399</ArticleId><ArticleId IdType="pubmed">28228446</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan D.Y., Sun H.L., Sun P.Y., Jian J.M., Li W.W., Shen Y.Y., Zeng F., Wang Y.J., Bu X.L. The Correlations between Plasma Fibrinogen with Amyloid-Beta and Tau Levels in Patients with Alzheimer&#x2019;s Disease. Front. Neurosci. 2020;14:625844. doi: 10.3389/fnins.2020.625844.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.625844</ArticleId><ArticleId IdType="pmc">PMC7859103</ArticleId><ArticleId IdType="pubmed">33551734</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisel J.W. Fibrinogen and fibrin. Adv. Protein Chem. 2005;70:247&#x2013;299. doi: 10.1016/S0065-3233(05)70008-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-3233(05)70008-5</ArticleId><ArticleId IdType="pubmed">15837518</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisel J.W., Litvinov R.I. Fibrin Formation, Structure and Properties. Subcell. Biochem. 2017;82:405&#x2013;456. doi: 10.1007/978-3-319-49674-0_13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-49674-0_13</ArticleId><ArticleId IdType="pmc">PMC5536120</ArticleId><ArticleId IdType="pubmed">28101869</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;bel K., Eichler S., Wiendl H., Chavakis T., Kleinschnitz C., Meuth S.G. The Coagulation Factors Fibrinogen, Thrombin, and Factor XII in Inflammatory Disorders&#x2014;A Systematic Review. Front. Immunol. 2018;9:1731. doi: 10.3389/fimmu.2018.01731.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01731</ArticleId><ArticleId IdType="pmc">PMC6077258</ArticleId><ArticleId IdType="pubmed">30105021</ArticleId></ArticleIdList></Reference><Reference><Citation>Litvinov R.I., Pieters M., de Lange-Loots Z., Weisel J.W. Fibrinogen and Fibrin. Subcell. Biochem. 2021;96:471&#x2013;501. doi: 10.1007/978-3-030-58971-4_15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-58971-4_15</ArticleId><ArticleId IdType="pubmed">33252741</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr M.E., Jr., Hardin C.L. Fibrin has larger pores when formed in the presence of erythrocytes. Am. J. Physiol. 1987;253:H1069&#x2013;H1073. doi: 10.1152/ajpheart.1987.253.5.H1069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1987.253.5.H1069</ArticleId><ArticleId IdType="pubmed">3688251</ArticleId></ArticleIdList></Reference><Reference><Citation>Collet J.P., Lesty C., Montalescot G., Weisel J.W. Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots. J. Biol. Chem. 2003;278:21331&#x2013;21335. doi: 10.1074/jbc.M212734200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M212734200</ArticleId><ArticleId IdType="pubmed">12642590</ArticleId></ArticleIdList></Reference><Reference><Citation>Weigandt K.M., White N., Chung D., Ellingson E., Wang Y., Fu X., Pozzo D.C. Fibrin clot structure and mechanics associated with specific oxidation of methionine residues in fibrinogen. Biophys. J. 2012;103:2399&#x2013;2407. doi: 10.1016/j.bpj.2012.10.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2012.10.036</ArticleId><ArticleId IdType="pmc">PMC3514520</ArticleId><ArticleId IdType="pubmed">23283239</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyisoylu H., Hazekamp E.D., Cruts J., Koenderink G.H., de Maat M.P.M. Flow affects the structural and mechanical properties of the fibrin network in plasma clots. J. Mater. Sci. Mater. Med. 2024;35:8. doi: 10.1007/s10856-024-06775-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10856-024-06775-1</ArticleId><ArticleId IdType="pmc">PMC10824866</ArticleId><ArticleId IdType="pubmed">38285167</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakharov A., Awan M., Cheng T., Gopinath A., Lee S.J., Ramasubramanian A.K., Dasbiswas K. Clots reveal anomalous elastic behavior of fiber networks. Sci. Adv. 2024;10:eadh1265. doi: 10.1126/sciadv.adh1265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.adh1265</ArticleId><ArticleId IdType="pmc">PMC10780871</ArticleId><ArticleId IdType="pubmed">38198546</ArticleId></ArticleIdList></Reference><Reference><Citation>Wufsus A.R., Macera N.E., Neeves K.B. The hydraulic permeability of blood clots as a function of fibrin and platelet density. Biophys. J. 2013;104:1812&#x2013;1823. doi: 10.1016/j.bpj.2013.02.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2013.02.055</ArticleId><ArticleId IdType="pmc">PMC3628570</ArticleId><ArticleId IdType="pubmed">23601328</ArticleId></ArticleIdList></Reference><Reference><Citation>Risman R.A., Kirby N.C., Bannish B.E., Hudson N.E., Tutwiler V. Fibrinolysis: An illustrated review. Res. Pract. Thromb. Haemost. 2023;7:100081. doi: 10.1016/j.rpth.2023.100081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rpth.2023.100081</ArticleId><ArticleId IdType="pmc">PMC10024051</ArticleId><ArticleId IdType="pubmed">36942151</ArticleId></ArticleIdList></Reference><Reference><Citation>Anfinsen C.B., Haber E., Sela M., White F.H. The kinetics of formation of native ribonuclease during oxidation of the reduced polypeptide chain. Proc. Natl. Acad. Sci. USA. 1961;47:1309&#x2013;1314. doi: 10.1073/pnas.47.9.1309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.47.9.1309</ArticleId><ArticleId IdType="pmc">PMC223141</ArticleId><ArticleId IdType="pubmed">13683522</ArticleId></ArticleIdList></Reference><Reference><Citation>Anfinsen C.B. Principles that govern the folding of protein chains. Science. 1973;181:223&#x2013;230. doi: 10.1126/science.181.4096.223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.181.4096.223</ArticleId><ArticleId IdType="pubmed">4124164</ArticleId></ArticleIdList></Reference><Reference><Citation>Levinthal C. How to Fold Graciously; Proceedings of the Mossbauer Spectroscopy in Biological Systems; Monticello, IL, USA. 17&#x2013;18 March 1969; pp. 22&#x2013;24.</Citation></Reference><Reference><Citation>Mart&#xed;nez L. Introducing the Levinthal&#x2019;s Protein Folding Paradox and Its Solution. J. Chem. Educ. 2014;91:1918&#x2013;1923. doi: 10.1021/ed300302h.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ed300302h</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguzzi A., Lakkaraju A.K.K. Cell Biology of Prions and Prionoids: A Status Report. Trends Cell Biol. 2016;26:40&#x2013;51. doi: 10.1016/j.tcb.2015.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2015.08.007</ArticleId><ArticleId IdType="pubmed">26455408</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: Lessons from and for blood clotting. Prog. Biophys. Mol. Biol. 2017;123:16&#x2013;41. doi: 10.1016/j.pbiomolbio.2016.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbiomolbio.2016.08.006</ArticleId><ArticleId IdType="pubmed">27554450</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. Are fibrinaloid microclots a cause of autoimmunity in Long Covid and other post-infection diseases? Biochem. J. 2023;480:1217&#x2013;1240. doi: 10.1042/BCJ20230241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20230241</ArticleId><ArticleId IdType="pubmed">37584410</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheckel C., Aguzzi A. Prions, prionoids and protein misfolding disorders. Nat. Rev. Genet. 2018;19:405&#x2013;418. doi: 10.1038/s41576-018-0011-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-018-0011-4</ArticleId><ArticleId IdType="pubmed">29713012</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter L.L., Looger L.L. Extant fold-switching proteins are widespread. Proc. Natl. Acad. Sci. USA. 2018;115:5968&#x2013;5973. doi: 10.1073/pnas.1800168115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1800168115</ArticleId><ArticleId IdType="pmc">PMC6003340</ArticleId><ArticleId IdType="pubmed">29784778</ArticleId></ArticleIdList></Reference><Reference><Citation>LiWang A., Porter L.L., Wang L.P. Fold-switching proteins. Biopolymers. 2021;112:e23478. doi: 10.1002/bip.23478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bip.23478</ArticleId><ArticleId IdType="pubmed">34694634</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter L.L. Fluid protein fold space and its implications. Bioessays. 2023;45:e2300057. doi: 10.1002/bies.202300057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.202300057</ArticleId><ArticleId IdType="pmc">PMC10529699</ArticleId><ArticleId IdType="pubmed">37431685</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim A.K., Porter L.L. Functional and Regulatory Roles of Fold-Switching Proteins. Structure. 2021;29:6&#x2013;14. doi: 10.1016/j.str.2020.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2020.10.006</ArticleId><ArticleId IdType="pmc">PMC8184262</ArticleId><ArticleId IdType="pubmed">33176159</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N., Das M., LiWang A., Wang L.P. Sequence-Based Prediction of Metamorphic Behavior in Proteins. Biophys. J. 2020;119:1380&#x2013;1390. doi: 10.1016/j.bpj.2020.07.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2020.07.034</ArticleId><ArticleId IdType="pmc">PMC7567988</ArticleId><ArticleId IdType="pubmed">32937108</ArticleId></ArticleIdList></Reference><Reference><Citation>Das M., Chen N., LiWang A., Wang L.P. Identification and characterization of metamorphic proteins: Current and future perspectives. Biopolymers. 2021;112:e23473. doi: 10.1002/bip.23473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bip.23473</ArticleId><ArticleId IdType="pubmed">34528703</ArticleId></ArticleIdList></Reference><Reference><Citation>Artsimovitch I., Ramirez-Sarmiento C.A. Metamorphic proteins under a computational microscope: Lessons from a fold-switching RfaH protein. Comput. Struct. Biotechnol. J. 2022;20:5824&#x2013;5837. doi: 10.1016/j.csbj.2022.10.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2022.10.024</ArticleId><ArticleId IdType="pmc">PMC9630627</ArticleId><ArticleId IdType="pubmed">36382197</ArticleId></ArticleIdList></Reference><Reference><Citation>Retamal-Farf&#xe1;n I., Gonz&#xe1;lez-Higueras J., Galaz-Davison P., Rivera M., Ram&#xed;rez-Sarmiento C.A. Exploring the structural acrobatics of fold-switching proteins using simplified structure-based models. Biophys. Rev. 2023;15:787&#x2013;799. doi: 10.1007/s12551-023-01087-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12551-023-01087-0</ArticleId><ArticleId IdType="pmc">PMC10480104</ArticleId><ArticleId IdType="pubmed">37681096</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter L.L., Artsimovitch I., Ramirez-Sarmiento C.A. Metamorphic proteins and how to find them. Curr. Opin. Struct. Biol. 2024;86:102807. doi: 10.1016/j.sbi.2024.102807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2024.102807</ArticleId><ArticleId IdType="pmc">PMC11102287</ArticleId><ArticleId IdType="pubmed">38537533</ArticleId></ArticleIdList></Reference><Reference><Citation>Strodel B. Energy Landscapes of Protein Aggregation and Conformation Switching in Intrinsically Disordered Proteins. J. Mol. Biol. 2021;433:167182. doi: 10.1016/j.jmb.2021.167182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2021.167182</ArticleId><ArticleId IdType="pubmed">34358545</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer J.W., Chakravarty D., Chen E.A., Porter L.L. Sequence clustering confounds AlphaFold2. bioRxiv. 2024 doi: 10.1101/2024.01.05.574434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.01.05.574434</ArticleId></ArticleIdList></Reference><Reference><Citation>Casadevall G., Duran C., Est&#xe9;vez-Gay M., Osuna S. Estimating conformational heterogeneity of tryptophan synthase with a template-based Alphafold2 approach. Protein Sci. 2022;31:e4426. doi: 10.1002/pro.4426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.4426</ArticleId><ArticleId IdType="pmc">PMC9601780</ArticleId><ArticleId IdType="pubmed">36173176</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra S., Looger L.L., Porter L.L. A sequence-based method for predicting extant fold switchers that undergo alpha-helix &lt;--&gt; beta-strand transitions. Biopolymers. 2021;112:e23471. doi: 10.1002/bip.23471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bip.23471</ArticleId><ArticleId IdType="pmc">PMC8545793</ArticleId><ArticleId IdType="pubmed">34498740</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter L.L., Chakravarty D., Schafer J.W., Chen E.A. ColabFold predicts alternative protein structures from single sequences, coevolution unnecessary for AF-cluster. bioRxiv. 2023 doi: 10.1101/2023.11.21.567977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.11.21.567977</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y.G., Cohen S.E., Phong C., Myers W.K., Kim Y.I., Tseng R., Lin J., Zhang L., Boyd J.S., Lee Y., et al. Circadian rhythms. A protein fold switch joins the circadian oscillator to clock output in cyanobacteria. Science. 2015;349:324&#x2013;328. doi: 10.1126/science.1260031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1260031</ArticleId><ArticleId IdType="pmc">PMC4506712</ArticleId><ArticleId IdType="pubmed">26113641</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarty D., Sreenivasan S., Swint-Kruse L., Porter L.L. Identification of a covert evolutionary pathway between two protein folds. Nat. Commun. 2023;14:3177. doi: 10.1038/s41467-023-38519-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-38519-0</ArticleId><ArticleId IdType="pmc">PMC10235069</ArticleId><ArticleId IdType="pubmed">37264049</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer J.W., Porter L.L. Evolutionary selection of proteins with two folds. Nat. Commun. 2023;14:5478. doi: 10.1038/s41467-023-41237-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-41237-2</ArticleId><ArticleId IdType="pmc">PMC10482954</ArticleId><ArticleId IdType="pubmed">37673981</ArticleId></ArticleIdList></Reference><Reference><Citation>Siemer A.B. What makes functional amyloids work? Crit. Rev. Biochem. Mol. Biol. 2022;57:399&#x2013;411. doi: 10.1080/10409238.2022.2113030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10409238.2022.2113030</ArticleId><ArticleId IdType="pmc">PMC9588633</ArticleId><ArticleId IdType="pubmed">35997712</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter L.L., He Y., Chen Y., Orban J., Bryan P.N. Subdomain interactions foster the design of two protein pairs with approximately 80% sequence identity but different folds. Biophys. J. 2015;108:154&#x2013;162. doi: 10.1016/j.bpj.2014.10.073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2014.10.073</ArticleId><ArticleId IdType="pmc">PMC4286614</ArticleId><ArticleId IdType="pubmed">25564862</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter L.L. Predictable fold switching by the SARS-CoV-2 protein ORF9b. Protein Sci. 2021;30:1723&#x2013;1729. doi: 10.1002/pro.4097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.4097</ArticleId><ArticleId IdType="pmc">PMC8242659</ArticleId><ArticleId IdType="pubmed">33934422</ArticleId></ArticleIdList></Reference><Reference><Citation>Nystr&#xf6;m S., Hammarstr&#xf6;m P. Amyloidogenesis of SARS-CoV-2 Spike Protein. J. Am. Chem. Soc. 2022;144:8945&#x2013;8950. doi: 10.1021/jacs.2c03925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.2c03925</ArticleId><ArticleId IdType="pmc">PMC9136918</ArticleId><ArticleId IdType="pubmed">35579205</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhardwaj T., Gadhave K., Kapuganti S.K., Kumar P., Brotzakis Z.F., Saumya K.U., Nayak N., Kumar A., Joshi R., Mukherjee B., et al. Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes. Nat. Commun. 2023;14:945. doi: 10.1038/s41467-023-36234-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-36234-4</ArticleId><ArticleId IdType="pmc">PMC9940680</ArticleId><ArticleId IdType="pubmed">36806058</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpell L.C., Benson M., Liepnieks J.J., Fraser P.E. Structural analyses of fibrinogen amyloid fibrils. Amyloid. 2007;14:199&#x2013;203. doi: 10.1080/13506120701461111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13506120701461111</ArticleId><ArticleId IdType="pubmed">17701467</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamolodchikov D., Berk-Rauch H.E., Oren D.A., Stor D.S., Singh P.K., Kawasaki M., Aso K., Strickland S., Ahn H.J. Biochemical and structural analysis of the interaction between beta-amyloid and fibrinogen. Blood. 2016;128:1144&#x2013;1151. doi: 10.1182/blood-2016-03-705228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2016-03-705228</ArticleId><ArticleId IdType="pmc">PMC5000847</ArticleId><ArticleId IdType="pubmed">27389717</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn H.J., Chen Z.L., Zamolodchikov D., Norris E.H., Strickland S. Interactions of beta-amyloid peptide with fibrinogen and coagulation factor XII may contribute to Alzheimer&#x2019;s disease. Curr. Opin. Hematol. 2017;24:427&#x2013;431. doi: 10.1097/MOH.0000000000000368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOH.0000000000000368</ArticleId><ArticleId IdType="pmc">PMC5540762</ArticleId><ArticleId IdType="pubmed">28661939</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P.K., Berk-Rauch H.E., Soplop N., Uryu K., Strickland S., Ahn H.J. Analysis of beta-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy. J. Vis. Exp. 2018:e58475. doi: 10.3791/58475.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/58475</ArticleId><ArticleId IdType="pmc">PMC6394827</ArticleId><ArticleId IdType="pubmed">30582601</ArticleId></ArticleIdList></Reference><Reference><Citation>Cajamarca S.A., Norris E.H., van der Weerd L., Strickland S., Ahn H.J. Cerebral amyloid angiopathy-linked beta-amyloid mutations promote cerebral fibrin deposits via increased binding affinity for fibrinogen. Proc. Natl. Acad. Sci. USA. 2020;117:14482&#x2013;14492. doi: 10.1073/pnas.1921327117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1921327117</ArticleId><ArticleId IdType="pmc">PMC7322009</ArticleId><ArticleId IdType="pubmed">32518112</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen F.E., Prusiner S.B. Pathologic conformations of prion proteins. Annu. Rev. Biochem. 1998;67:793&#x2013;819. doi: 10.1146/annurev.biochem.67.1.793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.67.1.793</ArticleId><ArticleId IdType="pubmed">9759504</ArticleId></ArticleIdList></Reference><Reference><Citation>Matiiv A.B., Trubitsina N.P., Matveenko A.G., Barbitoff Y.A., Zhouravleva G.A., Bondarev S.A. Structure and Polymorphism of Amyloid and Amyloid-Like Aggregates. Biochemistry. 2022;87:450&#x2013;463. doi: 10.1134/S0006297922050066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297922050066</ArticleId><ArticleId IdType="pubmed">35790379</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson R., Sawaya M.R., Balbirnie M., Madsen A.O., Riekel C., Grothe R., Eisenberg D. Structure of the cross-beta spine of amyloid-like fibrils. Nature. 2005;435:773&#x2013;778. doi: 10.1038/nature03680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03680</ArticleId><ArticleId IdType="pmc">PMC1479801</ArticleId><ArticleId IdType="pubmed">15944695</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabat&#xe9; R., Ventura S. Cross-beta-sheet supersecondary structure in amyloid folds: Techniques for detection and characterization. Methods Mol. Biol. 2013;932:237&#x2013;257. doi: 10.1007/978-1-62703-065-6_15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-62703-065-6_15</ArticleId><ArticleId IdType="pubmed">22987357</ArticleId></ArticleIdList></Reference><Reference><Citation>Saiki M., Shiba K., Okumura M. Structural stability of amyloid fibrils depends on the existence of the peripheral sequence near the core cross-beta region. FEBS Lett. 2015;589:3541&#x2013;3547. doi: 10.1016/j.febslet.2015.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2015.10.015</ArticleId><ArticleId IdType="pubmed">26497084</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallardo R., Ranson N.A., Radford S.E. Amyloid structures: Much more than just a cross-beta fold. Curr. Opin. Struct. Biol. 2020;60:7&#x2013;16. doi: 10.1016/j.sbi.2019.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2019.09.001</ArticleId><ArticleId IdType="pubmed">31683043</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonay V., Dunne M.P., Caceres-Delpiano J., Kajava A.V. Developing machine-learning-based amyloid predictors with Cross-Beta DB. bioRxiv. 2024 doi: 10.1101/2024.02.12.579644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.02.12.579644</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahn T.R., Makin O.S., Morris K.L., Marshall K.E., Tian P., Sikorski P., Serpell L.C. The common architecture of cross-beta amyloid. J. Mol. Biol. 2010;395:717&#x2013;727. doi: 10.1016/j.jmb.2009.09.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2009.09.039</ArticleId><ArticleId IdType="pubmed">19781557</ArticleId></ArticleIdList></Reference><Reference><Citation>Sipe J.D., Cohen A.S. Review: History of the amyloid fibril. J. Struct. Biol. 2000;130:88&#x2013;98. doi: 10.1006/jsbi.2000.4221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jsbi.2000.4221</ArticleId><ArticleId IdType="pubmed">10940217</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhyay A., Mishra A. Amyloids of multiple species: Are they helpful in survival? Biol. Rev. Camb. Philos. Soc. 2018;93:1363&#x2013;1386. doi: 10.1111/brv.12399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/brv.12399</ArticleId><ArticleId IdType="pubmed">29436097</ArticleId></ArticleIdList></Reference><Reference><Citation>Willbold D., Strodel B., Schroder G.F., Hoyer W., Heise H. Amyloid-type Protein Aggregation and Prion-like Properties of Amyloids. Chem. Rev. 2021;121:8285&#x2013;8307. doi: 10.1021/acs.chemrev.1c00196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrev.1c00196</ArticleId><ArticleId IdType="pubmed">34137605</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottwald J., R&#xf6;cken C. The amyloid proteome: A systematic review and proposal of a protein classification system. Crit. Rev. Biochem. Mol. Biol. 2021;56:526&#x2013;542. doi: 10.1080/10409238.2021.1937926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10409238.2021.1937926</ArticleId><ArticleId IdType="pubmed">34311636</ArticleId></ArticleIdList></Reference><Reference><Citation>Louros N., Schymkowitz J., Rousseau F. Mechanisms and pathology of protein misfolding and aggregation. Nat. Rev. Mol. Cell Biol. 2023;24:912&#x2013;933. doi: 10.1038/s41580-023-00647-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-023-00647-2</ArticleId><ArticleId IdType="pubmed">37684425</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaels T.C.T., Qian D., &#x160;ari&#x107; A., Vendruscolo M., Linse S., Knowles T.P.J. Amyloid formation as a protein phase transition. Nat. Phys. 2023;5:379&#x2013;397. doi: 10.1038/s42254-023-00598-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42254-023-00598-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei G., Su Z., Reynolds N.P., Arosio P., Hamley I.W., Gazit E., Mezzenga R. Self-assembling peptide and protein amyloids: From structure to tailored function in nanotechnology. Chem. Soc. Rev. 2017;46:4661&#x2013;4708. doi: 10.1039/C6CS00542J.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C6CS00542J</ArticleId><ArticleId IdType="pmc">PMC6364806</ArticleId><ArticleId IdType="pubmed">28530745</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobler C., van Tongeren M., Gettemans J., Kell D., Pretorius E. Alzheimer-type dementia: A systems view provides a unifying explanation of its development. J. Alzheimer&#x2019;s Dis. 2023;91:43&#x2013;70. doi: 10.3233/JAD-220720.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220720</ArticleId><ArticleId IdType="pubmed">36442193</ArticleId></ArticleIdList></Reference><Reference><Citation>Blancas-Mej&#xed;a L.M., Ramirez-Alvarado M. Systemic amyloidoses. Annu. Rev. Biochem. 2013;82:745&#x2013;774. doi: 10.1146/annurev-biochem-072611-130030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-072611-130030</ArticleId><ArticleId IdType="pmc">PMC4044913</ArticleId><ArticleId IdType="pubmed">23451869</ArticleId></ArticleIdList></Reference><Reference><Citation>Buxbaum J.N., Linke R.P. A molecular history of the amyloidoses. J. Mol. Biol. 2012;421:142&#x2013;159. doi: 10.1016/j.jmb.2012.01.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2012.01.024</ArticleId><ArticleId IdType="pubmed">22321796</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavatelli F., di Fonzo A., Palladini G., Merlini G. Systemic amyloidoses and proteomics: The state of the art. EuPA Open Proteom. 2016;11:4&#x2013;10. doi: 10.1016/j.euprot.2016.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euprot.2016.02.003</ArticleId><ArticleId IdType="pmc">PMC5988550</ArticleId><ArticleId IdType="pubmed">29900105</ArticleId></ArticleIdList></Reference><Reference><Citation>Palladini G., Merlini G. Systemic amyloidoses: What an internist should know. Eur. J. Intern. Med. 2013;24:729&#x2013;739. doi: 10.1016/j.ejim.2013.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2013.10.007</ArticleId><ArticleId IdType="pubmed">24262289</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevone A., Merlini G., Nuvolone M. Treating Protein Misfolding Diseases: Therapeutic Successes Against Systemic Amyloidoses. Front. Pharmacol. 2020;11:1024. doi: 10.3389/fphar.2020.01024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.01024</ArticleId><ArticleId IdType="pmc">PMC7366848</ArticleId><ArticleId IdType="pubmed">32754033</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevzglyadova O.V., Mikhailova E.V., Soidla T.R. Yeast red pigment, protein aggregates, and amyloidoses: A review. Cell Tissue Res. 2022;388:211&#x2013;223. doi: 10.1007/s00441-022-03609-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-022-03609-w</ArticleId><ArticleId IdType="pubmed">35258715</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy M., Nath A.K., Pal I., Dey S.G. Second Sphere Interactions in Amyloidogenic Diseases. Chem. Rev. 2022;122:12132&#x2013;12206. doi: 10.1021/acs.chemrev.1c00941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrev.1c00941</ArticleId><ArticleId IdType="pubmed">35471949</ArticleId></ArticleIdList></Reference><Reference><Citation>Burdukiewicz M., Sobczyk P., R&#xf6;diger S., Duda-Madej A., Mackiewicz P., Kotulska M. Amyloidogenic motifs revealed by n-gram analysis. Sci. Rep. 2017;7:12961. doi: 10.1038/s41598-017-13210-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-13210-9</ArticleId><ArticleId IdType="pmc">PMC5636826</ArticleId><ArticleId IdType="pubmed">29021608</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding F., LaRocque J.J., Dokholyan N.V. Direct observation of protein folding, aggregation, and a prion-like conformational conversion. J. Biol. Chem. 2005;280:40235&#x2013;40240. doi: 10.1074/jbc.M506372200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M506372200</ArticleId><ArticleId IdType="pubmed">16204250</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulatskaya A.I., Kosolapova A.O., Bobylev A.G., Belousov M.V., Antonets K.S., Sulatsky M.I., Kuznetsova I.M., Turoverov K.K., Stepanenko O.V., Nizhnikov A.A. beta-Barrels and Amyloids: Structural Transitions, Biological Functions, and Pathogenesis. Int. J. Mol. Sci. 2021;22:11316. doi: 10.3390/ijms222111316.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222111316</ArticleId><ArticleId IdType="pmc">PMC8582884</ArticleId><ArticleId IdType="pubmed">34768745</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiti F., Dobson C.M. Amyloid formation by globular proteins under native conditions. Nat. Chem. Biol. 2009;5:15&#x2013;22. doi: 10.1038/nchembio.131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.131</ArticleId><ArticleId IdType="pubmed">19088715</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge X., Sun Y., Ding F. Structures and dynamics of beta-barrel oligomer intermediates of amyloid-beta16-22 aggregation. Biochim. Biophys. Acta Biomembr. 2018;1860:1687&#x2013;1697. doi: 10.1016/j.bbamem.2018.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2018.03.011</ArticleId><ArticleId IdType="pmc">PMC6145138</ArticleId><ArticleId IdType="pubmed">29550287</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge X., Yang Y., Sun Y., Cao W., Ding F. Islet Amyloid Polypeptide Promotes Amyloid-Beta Aggregation by Binding-Induced Helix-Unfolding of the Amyloidogenic Core. ACS Chem. Neurosci. 2018;9:967&#x2013;975. doi: 10.1021/acschemneuro.7b00396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.7b00396</ArticleId><ArticleId IdType="pmc">PMC5955824</ArticleId><ArticleId IdType="pubmed">29378116</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Ge X., Xing Y., Wang B., Ding F. beta-barrel Oligomers as Common Intermediates of Peptides Self-Assembling into Cross-beta Aggregates. Sci. Rep. 2018;8:10353. doi: 10.1038/s41598-018-28649-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-28649-7</ArticleId><ArticleId IdType="pmc">PMC6037789</ArticleId><ArticleId IdType="pubmed">29985420</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley L.H., Wei Y., Thumfort P., Wurth C., Hecht M.H. Protein design by binary patterning of polar and nonpolar amino acids. Methods Mol. Biol. 2007;352:155&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pubmed">17041264</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xe4;ndrich M. On the structural definition of amyloid fibrils and other polypeptide aggregates. Cell. Mol. Life Sci. 2007;64:2066&#x2013;2078. doi: 10.1007/s00018-007-7110-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-007-7110-2</ArticleId><ArticleId IdType="pmc">PMC11138455</ArticleId><ArticleId IdType="pubmed">17530168</ArticleId></ArticleIdList></Reference><Reference><Citation>Keresztes L., Szogi E., Varga B., Farkas V., Perczel A., Grolmusz V. Succinct Amyloid and Nonamyloid Patterns in Hexapeptides. ACS Omega. 2022;7:35532&#x2013;35537. doi: 10.1021/acsomega.2c02513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.2c02513</ArticleId><ArticleId IdType="pmc">PMC9558248</ArticleId><ArticleId IdType="pubmed">36249386</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotulska M., Wojciechowski J.W. Bioinformatics Methods in Predicting Amyloid Propensity of Peptides and Proteins. Methods Mol. Biol. 2022;2340:1&#x2013;15. doi: 10.1007/978-1-0716-1546-1_1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-1546-1_1</ArticleId><ArticleId IdType="pubmed">35167067</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatafta H., Khaled M., Kav B., Olubiyi O.O., Strodel B. A brief history of amyloid aggregation simulations. Wires Comput. Mol. Sci. 2024;14:e1703. doi: 10.1002/wcms.1703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wcms.1703</ArticleId></ArticleIdList></Reference><Reference><Citation>Beerten J., Van Durme J., Gallardo R., Capriotti E., Serpell L., Rousseau F., Schymkowitz J. WALTZ-DB: A benchmark database of amyloidogenic hexapeptides. Bioinformatics. 2015;31:1698&#x2013;1700. doi: 10.1093/bioinformatics/btv027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btv027</ArticleId><ArticleId IdType="pubmed">25600945</ArticleId></ArticleIdList></Reference><Reference><Citation>Burdukiewicz M., Rafacz D., Barbach A., Hubicka K., B&#x105;kaaronla L., Lassota A., Stecko J., Szyma&#x144;ska N., Wojciechowski J.W., Kozakiewicz D., et al. AmyloGraph: A comprehensive database of amyloid-amyloid interactions. Nucleic Acids Res. 2023;51:D352&#x2013;D357. doi: 10.1093/nar/gkac882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkac882</ArticleId><ArticleId IdType="pmc">PMC9825533</ArticleId><ArticleId IdType="pubmed">36243982</ArticleId></ArticleIdList></Reference><Reference><Citation>Argos P., Rao J.K., Hargrave P.A. Structural prediction of membrane-bound proteins. Eur. J. Biochem. 1982;128:565&#x2013;575. doi: 10.1111/j.1432-1033.1982.tb07002.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-1033.1982.tb07002.x</ArticleId><ArticleId IdType="pubmed">7151796</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaskaran R., Ponnuswamy P. Positional flexibilities of amino acid residues in globular proteins. Int. J. Pept. Protein Res. 1988;32:241&#x2013;255. doi: 10.1111/j.1399-3011.1988.tb01258.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-3011.1988.tb01258.x</ArticleId><ArticleId IdType="pubmed">6480218</ArticleId></ArticleIdList></Reference><Reference><Citation>Charton M., Charton B.I. The structural dependence of amino acid hydrophobicity parameters. J. Theor. Biol. 1982;99:629&#x2013;644. doi: 10.1016/0022-5193(82)90191-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-5193(82)90191-6</ArticleId><ArticleId IdType="pubmed">7183857</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C.A., Berg J.M. Thermodynamic beta-sheet propensities measured using a zinc-finger host peptide. Nature. 1993;362:267&#x2013;270. doi: 10.1038/362267a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362267a0</ArticleId><ArticleId IdType="pubmed">8459852</ArticleId></ArticleIdList></Reference><Reference><Citation>Planas-Iglesias J., Borko S., Swiatkowski J., Elias M., Havlasek M., Salamon O., Grakova E., Kunka A., Martinovic T., Damborsky J., et al. AggreProt: A web server for predicting and engineering aggregation prone regions in proteins. Nucleic Acids Res. 2024;52:W159&#x2013;W169. doi: 10.1093/nar/gkae420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkae420</ArticleId><ArticleId IdType="pmc">PMC11223854</ArticleId><ArticleId IdType="pubmed">38801076</ArticleId></ArticleIdList></Reference><Reference><Citation>Conchillo-Sol&#xe9; O., de Groot N.S., Avil&#xe9;s F.X., Vendrell J., Daura X., Ventura S. AGGRESCAN: A server for the prediction and evaluation of &#x201c;hot spots&#x201d; of aggregation in polypeptides. BMC Bioinform. 2007;8:65. doi: 10.1186/1471-2105-8-65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-8-65</ArticleId><ArticleId IdType="pmc">PMC1828741</ArticleId><ArticleId IdType="pubmed">17324296</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambrano R., Jamroz M., Szczasiuk A., Pujols J., Kmiecik S., Ventura S. AGGRESCAN3D (A3D): Server for prediction of aggregation properties of protein structures. Nucleic Acids Res. 2015;43:W306&#x2013;W313. doi: 10.1093/nar/gkv359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv359</ArticleId><ArticleId IdType="pmc">PMC4489226</ArticleId><ArticleId IdType="pubmed">25883144</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe1;rcenas O., Kuriata A., Zalewski M., Iglesias V., Pintado-Grima C., Firlik G., Burdukiewicz M., Kmiecik S., Ventura S. Aggrescan4D: Structure-informed analysis of pH-dependent protein aggregation. Nucleic Acids Res. 2024;52:W170&#x2013;W175. doi: 10.1093/nar/gkae382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkae382</ArticleId><ArticleId IdType="pmc">PMC11223845</ArticleId><ArticleId IdType="pubmed">38738618</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Wu Y., Liu H., He L., Deng X. AMYGNN: A Graph Convolutional Neural Network-Based Approach for Predicting Amyloid Formation from Polypeptides. J. Chem. Inf. Model. 2024;64:1751&#x2013;1762. doi: 10.1021/acs.jcim.3c02035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.3c02035</ArticleId><ArticleId IdType="pubmed">38408296</ArticleId></ArticleIdList></Reference><Reference><Citation>Wozniak P.P., Kotulska M. AmyLoad: Website dedicated to amyloidogenic protein fragments. Bioinformatics. 2015;31:3395&#x2013;3397. doi: 10.1093/bioinformatics/btv375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btv375</ArticleId><ArticleId IdType="pubmed">26088800</ArticleId></ArticleIdList></Reference><Reference><Citation>Bondarev S.A., Uspenskaya M.V., Leclercq J., Falgarone T., Zhouravleva G.A., Kajava A.V. AmyloComp: A Bioinformatic Tool for Prediction of Amyloid Co-aggregation. J. Mol. Biol. 2024;436:168437. doi: 10.1016/j.jmb.2024.168437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2024.168437</ArticleId><ArticleId IdType="pubmed">38185324</ArticleId></ArticleIdList></Reference><Reference><Citation>Szulc N., Burdukiewicz M., G&#x105;sior-G&#x142;ogowska M., Wojciechowski J.W., Chilimoniuk J., Mackiewicz P., &#x160;neideris T., Smirnovas V., Kotulska M. Bioinformatics methods for identification of amyloidogenic peptides show robustness to misannotated training data. Sci. Rep. 2021;11:8934. doi: 10.1038/s41598-021-86530-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-86530-6</ArticleId><ArticleId IdType="pmc">PMC8076271</ArticleId><ArticleId IdType="pubmed">33903613</ArticleId></ArticleIdList></Reference><Reference><Citation>Charoenkwan P., Ahmed S., Nantasenamat C., Quinn J.M.W., Moni M.A., Lio P., Shoombuatong W. AMYPred-FRL is a novel approach for accurate prediction of amyloid proteins by using feature representation learning. Sci. Rep. 2022;12:7697. doi: 10.1038/s41598-022-11897-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-11897-z</ArticleId><ArticleId IdType="pmc">PMC9095707</ArticleId><ArticleId IdType="pubmed">35546347</ArticleId></ArticleIdList></Reference><Reference><Citation>Varadi M., De Baets G., Vranken W.F., Tompa P., Pancsa R. AmyPro: A database of proteins with validated amyloidogenic regions. Nucleic Acids Res. 2018;46:D387&#x2013;D392. doi: 10.1093/nar/gkx950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx950</ArticleId><ArticleId IdType="pmc">PMC5753394</ArticleId><ArticleId IdType="pubmed">29040693</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A.B., Znassi N., Chateau M.T., Kajava A.V. A structure-based approach to predict predisposition to amyloidosis. Alzheimer&#x2019;s Dement. 2015;11:681&#x2013;690. doi: 10.1016/j.jalz.2014.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2014.06.007</ArticleId><ArticleId IdType="pubmed">25150734</ArticleId></ArticleIdList></Reference><Reference><Citation>Falgarone T., Villain E., Guettaf A., Leclercq J., Kajava A.V. TAPASS: Tool for annotation of protein amyloidogenicity in the context of other structural states. J. Struct. Biol. 2022;214:107840. doi: 10.1016/j.jsb.2022.107840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2022.107840</ArticleId><ArticleId IdType="pubmed">35149212</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabakaran R., Rawat P., Kumar S., Michael Gromiha M. ANuPP: A Versatile Tool to Predict Aggregation Nucleating Regions in Peptides and Proteins. J. Mol. Biol. 2021;433:166707. doi: 10.1016/j.jmb.2020.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2020.11.006</ArticleId><ArticleId IdType="pubmed">33972019</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryan A.W., Jr., Menke M., Cowen L.J., Lindquist S.L., Berger B. BETASCAN: Probable beta-amyloids identified by pairwise probabilistic analysis. PLoS Comput. Biol. 2009;5:e1000333. doi: 10.1371/journal.pcbi.1000333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1000333</ArticleId><ArticleId IdType="pmc">PMC2653728</ArticleId><ArticleId IdType="pubmed">19325876</ArticleId></ArticleIdList></Reference><Reference><Citation>Bondarev S.A., Bondareva O.V., Zhouravleva G.A., Kajava A.V. BetaSerpentine: A bioinformatics tool for reconstruction of amyloid structures. Bioinformatics. 2018;34:599&#x2013;608. doi: 10.1093/bioinformatics/btx629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btx629</ArticleId><ArticleId IdType="pubmed">29444233</ArticleId></ArticleIdList></Reference><Reference><Citation>Keresztes L., Szogi E., Varga B., Farkas V., Perczel A., Grolmusz V. The Budapest Amyloid Predictor and Its Applications. Biomolecules. 2021;11:500. doi: 10.3390/biom11040500.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11040500</ArticleId><ArticleId IdType="pmc">PMC8067080</ArticleId><ArticleId IdType="pubmed">33810341</ArticleId></ArticleIdList></Reference><Reference><Citation>Louros N., Rousseau F., Schymkowitz J. CORDAX web server: An online platform for the prediction and 3D visualization of aggregation motifs in protein sequences. Bioinformatics. 2024;40:btae279. doi: 10.1093/bioinformatics/btae279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btae279</ArticleId><ArticleId IdType="pmc">PMC11078773</ArticleId><ArticleId IdType="pubmed">38662570</ArticleId></ArticleIdList></Reference><Reference><Citation>Thangakani A.M., Nagarajan R., Kumar S., Sakthivel R., Velmurugan D., Gromiha M.M. CPAD, Curated Protein Aggregation Database: A Repository of Manually Curated Experimental Data on Protein and Peptide Aggregation. PLoS ONE. 2016;11:e0152949. doi: 10.1371/journal.pone.0152949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0152949</ArticleId><ArticleId IdType="pmc">PMC4820268</ArticleId><ArticleId IdType="pubmed">27043825</ArticleId></ArticleIdList></Reference><Reference><Citation>Citarella A.A., Di Biasi L., De Marco F., Tortora G. ENTAIL: yEt aNoTher amyloid fIbrils cLassifier. BMC Bioinform. 2022;23:517. doi: 10.1186/s12859-022-05070-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-022-05070-6</ArticleId><ArticleId IdType="pmc">PMC9714056</ArticleId><ArticleId IdType="pubmed">36456900</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasior P., Kotulska M. FISH Amyloid&#x2014;A new method for finding amyloidogenic segments in proteins based on site specific co-occurrence of aminoacids. BMC Bioinform. 2014;15:54. doi: 10.1186/1471-2105-15-54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-15-54</ArticleId><ArticleId IdType="pmc">PMC3941796</ArticleId><ArticleId IdType="pubmed">24564523</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzynskiy S.O., Lobanov M.Y., Galzitskaya O.V. FoldAmyloid: A method of prediction of amyloidogenic regions from protein sequence. Bioinformatics. 2010;26:326&#x2013;332. doi: 10.1093/bioinformatics/btp691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp691</ArticleId><ArticleId IdType="pubmed">20019059</ArticleId></ArticleIdList></Reference><Reference><Citation>Thangakani A.M., Kumar S., Nagarajan R., Velmurugan D., Gromiha M.M. GAP: Towards almost 100 percent prediction for beta-strand-mediated aggregating peptides with distinct morphologies. Bioinformatics. 2014;30:1983&#x2013;1990. doi: 10.1093/bioinformatics/btu167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu167</ArticleId><ArticleId IdType="pubmed">24681906</ArticleId></ArticleIdList></Reference><Reference><Citation>Munir F., Gul S., Asif A., Minhas F.A. MILAMP: Multiple Instance Prediction of Amyloid Proteins. IEEE/ACM Trans. Comput. Biol. Bioinform. 2021;18:1142&#x2013;1150. doi: 10.1109/TCBB.2019.2936846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TCBB.2019.2936846</ArticleId><ArticleId IdType="pubmed">31443048</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojciechowski J.W., Szczurek W., Szulc N., Szefczyk M., Kotulska M. PACT&#x2014;Prediction of amyloid cross-interaction by threading. Sci. Rep. 2023;13:22268. doi: 10.1038/s41598-023-48886-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-48886-9</ArticleId><ArticleId IdType="pmc">PMC10721876</ArticleId><ArticleId IdType="pubmed">38097650</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Escamilla A.M., Rousseau F., Schymkowitz J., Serrano L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat. Biotechnol. 2004;22:1302&#x2013;1306. doi: 10.1038/nbt1012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt1012</ArticleId><ArticleId IdType="pubmed">15361882</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh I., Seno F., Tosatto S.C., Trovato A. PASTA 2.0: An improved server for protein aggregation prediction. Nucleic Acids Res. 2014;42:W301&#x2013;W307. doi: 10.1093/nar/gku399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku399</ArticleId><ArticleId IdType="pmc">PMC4086119</ArticleId><ArticleId IdType="pubmed">24848016</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng Z., Zhang Z., Tian Z., Li Y., Wang G. ReRF-Pred: Predicting amyloidogenic regions of proteins based on their pseudo amino acid composition and tripeptide composition. BMC Bioinform. 2021;22:545. doi: 10.1186/s12859-021-04446-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-021-04446-4</ArticleId><ArticleId IdType="pmc">PMC8579573</ArticleId><ArticleId IdType="pubmed">34753427</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu M., Li Y., Wang C., Han K. RFAmyloid: A Web Server for Predicting Amyloid Proteins. Int. J. Mol. Sci. 2018;19:2071. doi: 10.3390/ijms19072071.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19072071</ArticleId><ArticleId IdType="pmc">PMC6073578</ArticleId><ArticleId IdType="pubmed">30013015</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurer-Stroh S., Debulpaep M., Kuemmerer N., Lopez de la Paz M., Martins I.C., Reumers J., Morris K.L., Copland A., Serpell L., Serrano L., et al. Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat. Methods. 2010;7:237&#x2013;242. doi: 10.1038/nmeth.1432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1432</ArticleId><ArticleId IdType="pubmed">20154676</ArticleId></ArticleIdList></Reference><Reference><Citation>Louros N., Konstantoulea K., De Vleeschouwer M., Ramakers M., Schymkowitz J., Rousseau F. WALTZ-DB 2.0: An updated database containing structural information of experimentally determined amyloid-forming peptides. Nucleic Acids Res. 2020;48:D389&#x2013;D393. doi: 10.1093/nar/gkz758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz758</ArticleId><ArticleId IdType="pmc">PMC6943037</ArticleId><ArticleId IdType="pubmed">31504823</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldschmidt L., Teng P.K., Riek R., Eisenberg D. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc. Natl. Acad. Sci. USA. 2010;107:3487&#x2013;3492. doi: 10.1073/pnas.0915166107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0915166107</ArticleId><ArticleId IdType="pmc">PMC2840437</ArticleId><ArticleId IdType="pubmed">20133726</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabakaran R., Goel D., Kumar S., Gromiha M.M. Aggregation prone regions in human proteome: Insights from large-scale data analyses. Proteins. 2017;85:1099&#x2013;1118. doi: 10.1002/prot.25276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.25276</ArticleId><ArticleId IdType="pubmed">28257595</ArticleId></ArticleIdList></Reference><Reference><Citation>Danilov L.G., Sukhanova X.V., Rogoza T.M., Antonova E.Y., Trubitsina N.P., Zhouravleva G.A., Bondarev S.A. Identification of New FG-Repeat Nucleoporins with Amyloid Properties. Int. J. Mol. Sci. 2023;24:8571. doi: 10.3390/ijms24108571.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24108571</ArticleId><ArticleId IdType="pmc">PMC10218210</ArticleId><ArticleId IdType="pubmed">37239918</ArticleId></ArticleIdList></Reference><Reference><Citation>Falgarone T., Villain E., Richard F., Osmanli Z., Kajava A.V. Census of exposed aggregation-prone regions in proteomes. Brief. Bioinform. 2023;24:bbad183. doi: 10.1093/bib/bbad183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbad183</ArticleId><ArticleId IdType="pubmed">37200152</ArticleId></ArticleIdList></Reference><Reference><Citation>Nizhnikov A.A., Antonets K.S., Inge-Vechtomov S.G. Amyloids: From Pathogenesis to Function. Biochemistry. 2015;80:1127&#x2013;1144. doi: 10.1134/S0006297915090047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297915090047</ArticleId><ArticleId IdType="pubmed">26555466</ArticleId></ArticleIdList></Reference><Reference><Citation>Carri&#xf3; M., Gonz&#xe1;lez-Montalb&#xe1;n N., Vera A., Villaverde A., Ventura S. Amyloid-like properties of bacterial inclusion bodies. J. Mol. Biol. 2005;347:1025&#x2013;1037. doi: 10.1016/j.jmb.2005.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2005.02.030</ArticleId><ArticleId IdType="pubmed">15784261</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagihi M.H.A., Bhattacharjee S. Amyloid Fibrillation of Insulin: Amelioration Strategies and Implications for Translation. ACS Pharmacol. Transl. Sci. 2022;5:1050&#x2013;1061. doi: 10.1021/acsptsci.2c00174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsptsci.2c00174</ArticleId><ArticleId IdType="pmc">PMC9667547</ArticleId><ArticleId IdType="pubmed">36407954</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller Y. Advancements and future directions in research of the roles of insulin in amyloid diseases. Biophys. Chem. 2022;281:106720. doi: 10.1016/j.bpc.2021.106720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpc.2021.106720</ArticleId><ArticleId IdType="pubmed">34823073</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua Q.X., Weiss M.A. Mechanism of insulin fibrillation: The structure of insulin under amyloidogenic conditions resembles a protein-folding intermediate. J. Biol. Chem. 2004;279:21449&#x2013;21460. doi: 10.1074/jbc.M314141200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M314141200</ArticleId><ArticleId IdType="pubmed">14988398</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo C.T., Chen Y.L., Hsu W.T., How S.C., Cheng Y.H., Hsueh S.S., Liu H.S., Lin T.H., Wu J.W., Wang S.S. Investigating the effects of erythrosine B on amyloid fibril formation derived from lysozyme. Int. J. Biol. Macromol. 2017;98:159&#x2013;168. doi: 10.1016/j.ijbiomac.2017.01.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2017.01.110</ArticleId><ArticleId IdType="pubmed">28137461</ArticleId></ArticleIdList></Reference><Reference><Citation>How S.C., Hsin A., Chen G.Y., Hsu W.T., Yang S.M., Chou W.L., Chou S.H., Wang S.S. Exploring the influence of brilliant blue G on amyloid fibril formation of lysozyme. Int. J. Biol. Macromol. 2019;38:37&#x2013;48. doi: 10.1016/j.ijbiomac.2019.07.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2019.07.055</ArticleId><ArticleId IdType="pubmed">31295491</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez C., Miti T., Hasecke F., Meisl G., Hoyer W., Muschol M., Ullah G. Mechanism of Fibril and Soluble Oligomer Formation in Amyloid Beta and Hen Egg White Lysozyme Proteins. J. Phys. Chem. B. 2019;123:5678&#x2013;5689. doi: 10.1021/acs.jpcb.9b02338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpcb.9b02338</ArticleId><ArticleId IdType="pmc">PMC6839771</ArticleId><ArticleId IdType="pubmed">31246474</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Xing L., Li X., Chen N., Liu L., Wang J., Zhou X., Liu S. Manganese Ion-Induced Amyloid Fibrillation Kinetics of Hen Egg White-Lysozyme in Thermal and Acidic Conditions. ACS Omega. 2023;8:16439&#x2013;16449. doi: 10.1021/acsomega.3c01531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.3c01531</ArticleId><ArticleId IdType="pmc">PMC10173442</ArticleId><ArticleId IdType="pubmed">37179629</ArticleId></ArticleIdList></Reference><Reference><Citation>Gancar M., Kurin E., Bednarikova Z., Marek J., Mucaji P., Nagy M., Gazova Z. Green tea leaf constituents inhibit the formation of lysozyme amyloid aggregates: An effect of mutual interactions. Int. J. Biol. Macromol. 2023;242:124856. doi: 10.1016/j.ijbiomac.2023.124856.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2023.124856</ArticleId><ArticleId IdType="pubmed">37178892</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A.N., Nabi F., Khan R.H. Mechanistic and biophysical insight into the inhibitory and disaggregase role of antibiotic moxifloxacin on human lysozyme amyloid formation. Biophys. Chem. 2023;298:107029. doi: 10.1016/j.bpc.2023.107029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpc.2023.107029</ArticleId><ArticleId IdType="pubmed">37150142</ArticleId></ArticleIdList></Reference><Reference><Citation>Swaminathan R., Ravi V.K., Kumar S., Kumar M.V., Chandra N. Lysozyme: A model protein for amyloid research. Adv. Protein Chem. Struct. Biol. 2011;84:63&#x2013;111. doi: 10.1016/B978-0-12-386483-3.00003-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-386483-3.00003-3</ArticleId><ArticleId IdType="pubmed">21846563</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy S., Srinivasan V.R., Arunagiri S., Mishra N., Bhatia A., Shejale K.P., Prajapati K.P., Kar K., Anand B.G. Molecular insights into the phase transition of lysozyme into amyloid nanostructures: Implications of therapeutic strategies in diverse pathological conditions. Adv. Colloid. Interface Sci. 2024;331:103205. doi: 10.1016/j.cis.2024.103205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cis.2024.103205</ArticleId><ArticleId IdType="pubmed">38875805</ArticleId></ArticleIdList></Reference><Reference><Citation>Muthu S.A., Qureshi A., Sharma R., Bisaria I., Parvez S., Grover S., Ahmad B. Redesigning the kinetics of lysozyme amyloid aggregation by cephalosporin molecules. J. Biomol. Struct. Dyn. 2024:1&#x2013;16. doi: 10.1080/07391102.2024.2335304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2024.2335304</ArticleId><ArticleId IdType="pubmed">38682862</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamada A., Herneke A., Lopez-Sanchez P., Harder C., Ornithopoulou E., Wu Q., Wei X., Schwartzkopf M., Muller-Buschbaum P., Roth S.V., et al. Hierarchical propagation of structural features in protein nanomaterials. Nanoscale. 2022;14:2502&#x2013;2510. doi: 10.1039/D1NR05571B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D1NR05571B</ArticleId><ArticleId IdType="pubmed">35103743</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Mezzenga R. Design principles of food gels. Nat. Food. 2020;1:106&#x2013;118. doi: 10.1038/s43016-019-0009-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43016-019-0009-x</ArticleId><ArticleId IdType="pubmed">37127997</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman M.M., Pires R.S., Herneke A., Gowda V., Langton M., Biverstal H., Lendel C. Food protein-derived amyloids do not accelerate amyloid beta aggregation. Sci. Rep. 2023;13:985. doi: 10.1038/s41598-023-28147-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-28147-5</ArticleId><ArticleId IdType="pmc">PMC9889329</ArticleId><ArticleId IdType="pubmed">36720893</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickner R.B., Edskes H.K., Bateman D.A., Kelly A.C., Gorkovskiy A., Dayani Y., Zhou A. Amyloid diseases of yeast: Prions are proteins acting as genes. Essays Biochem. 2014;56:193&#x2013;205. doi: 10.1042/bse0560193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bse0560193</ArticleId><ArticleId IdType="pmc">PMC9434491</ArticleId><ArticleId IdType="pubmed">25131596</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickner R.B., Edskes H.K., Gorkovskiy A., Bezsonov E.E., Stroobant E.E. Yeast and Fungal Prions: Amyloid-Handling Systems, Amyloid Structure, and Prion Biology. Adv. Genet. 2016;93:191&#x2013;236. doi: 10.1016/bs.adgen.2015.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.adgen.2015.12.003</ArticleId><ArticleId IdType="pmc">PMC9432818</ArticleId><ArticleId IdType="pubmed">26915272</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa Y., Shen H.C., Komi Y., Sugiyama S., Kurinomaru T., Tomabechi Y., Krayukhina E., Okamoto K., Yokoyama T., Shirouzu M., et al. Amyloid conformation-dependent disaggregation in a reconstituted yeast prion system. Nat. Chem. Biol. 2022;18:321&#x2013;331. doi: 10.1038/s41589-021-00951-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41589-021-00951-y</ArticleId><ArticleId IdType="pubmed">35177839</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouse S.L., Matthews S.J., Dueholm M.S. Ecology and Biogenesis of Functional Amyloids in Pseudomonas. J. Mol. Biol. 2018;430:3685&#x2013;3695. doi: 10.1016/j.jmb.2018.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2018.05.004</ArticleId><ArticleId IdType="pmc">PMC6173800</ArticleId><ArticleId IdType="pubmed">29753779</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivancic V., Ekanayake O., Lazo N. Binding Modes of Thioflavin T on the Surface of Amyloid Fibrils by NMR. ChemPhysChem. 2016;17:2461&#x2013;2464. doi: 10.1002/cphc.201600246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphc.201600246</ArticleId><ArticleId IdType="pubmed">27165642</ArticleId></ArticleIdList></Reference><Reference><Citation>Tycko R. Solid-state NMR studies of amyloid fibril structure. Annu. Rev. Phys. Chem. 2011;62:279&#x2013;299. doi: 10.1146/annurev-physchem-032210-103539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physchem-032210-103539</ArticleId><ArticleId IdType="pmc">PMC3191906</ArticleId><ArticleId IdType="pubmed">21219138</ArticleId></ArticleIdList></Reference><Reference><Citation>Artikis E., Kraus A., Caughey B. Structural biology of ex vivo mammalian prions. J. Biol. Chem. 2022;298:102181. doi: 10.1016/j.jbc.2022.102181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2022.102181</ArticleId><ArticleId IdType="pmc">PMC9293645</ArticleId><ArticleId IdType="pubmed">35752366</ArticleId></ArticleIdList></Reference><Reference><Citation>Martial B., Lef&#xe8;vre T., Auger M. Understanding amyloid fibril formation using protein fragments: Structural investigations via vibrational spectroscopy and solid-state NMR. Biophys. Rev. 2018;10:1133&#x2013;1149. doi: 10.1007/s12551-018-0427-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12551-018-0427-2</ArticleId><ArticleId IdType="pmc">PMC6082320</ArticleId><ArticleId IdType="pubmed">29855812</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek Y., Lee M. Solid-state NMR spectroscopic analysis for structure determination of a zinc-bound catalytic amyloid fibril. Methods Enzymol. 2024;697:435&#x2013;471. doi: 10.1016/bs.mie.2024.01.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.mie.2024.01.025</ArticleId><ArticleId IdType="pubmed">38816132</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;vestam S., Scheres S.H.W. High-throughput cryo-EM structure determination of amyloids. Faraday Discuss. 2022;240:243&#x2013;260. doi: 10.1039/D2FD00034B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D2FD00034B</ArticleId><ArticleId IdType="pmc">PMC9642048</ArticleId><ArticleId IdType="pubmed">35913272</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Arseni D., Zhang W., Huang M., Lovestam S., Schweighauser M., Kotecha A., Murzin A.G., Peak-Chew S.Y., Macdonald J., et al. Cryo-EM structures of amyloid-beta 42 filaments from human brains. Science. 2022;375:167&#x2013;172. doi: 10.1126/science.abm7285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm7285</ArticleId><ArticleId IdType="pmc">PMC7612234</ArticleId><ArticleId IdType="pubmed">35025654</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;cker R., Seuring C., Cazey C., Veith K., Garcia-Alai M., Gr&#xfc;newald K., Landau M. The Cryo-EM structures of two amphibian antimicrobial cross-beta amyloid fibrils. Nat. Commun. 2022;13:4356. doi: 10.1038/s41467-022-32039-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32039-z</ArticleId><ArticleId IdType="pmc">PMC9329304</ArticleId><ArticleId IdType="pubmed">35896552</ArticleId></ArticleIdList></Reference><Reference><Citation>Heerde T., Bansal A., Schmidt M., F&#xe4;ndrich M. Cryo-EM structure of a catalytic amyloid fibril. Sci. Rep. 2023;13:4070. doi: 10.1038/s41598-023-30711-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-30711-y</ArticleId><ArticleId IdType="pmc">PMC10008563</ArticleId><ArticleId IdType="pubmed">36906667</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez A., Hoq M.R., Hallinan G.I., Li D., Bharath S.R., Vago F.S., Zhang X., Ozcan K.A., Newell K.L., Garringer H.J., et al. Cryo-EM structures of amyloid-beta and tau filaments in Down syndrome. Nat. Struct. Mol. Biol. 2024;31:903&#x2013;909. doi: 10.1038/s41594-024-01252-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-024-01252-3</ArticleId><ArticleId IdType="pmc">PMC11189299</ArticleId><ArticleId IdType="pubmed">38553642</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma K., Stockert F., Shenoy J., Berbon M., Abdul-Shukkoor M.B., Habenstein B., Loquet A., Schmidt M., F&#xe4;ndrich M. Cryo-EM observation of the amyloid key structure of polymorphic TDP-43 amyloid fibrils. Nat. Commun. 2024;15:486. doi: 10.1038/s41467-023-44489-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-44489-0</ArticleId><ArticleId IdType="pmc">PMC10784485</ArticleId><ArticleId IdType="pubmed">38212334</ArticleId></ArticleIdList></Reference><Reference><Citation>LeVine H., 3rd Thioflavine T interaction with synthetic Alzheimer&#x2019;s disease beta-amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci. 1993;2:404&#x2013;410. doi: 10.1002/pro.5560020312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.5560020312</ArticleId><ArticleId IdType="pmc">PMC2142377</ArticleId><ArticleId IdType="pubmed">8453378</ArticleId></ArticleIdList></Reference><Reference><Citation>Khurana R., Coleman C., Ionescu-Zanetti C., Carter S.A., Krishna V., Grover R.K., Roy R., Singh S. Mechanism of thioflavin T binding to amyloid fibrils. J. Struct. Biol. 2005;151:229&#x2013;238. doi: 10.1016/j.jsb.2005.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2005.06.006</ArticleId><ArticleId IdType="pubmed">16125973</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawe A., Sutter M., Jiskoot W. Extrinsic fluorescent dyes as tools for protein characterization. Pharm. Res. 2008;25:1487&#x2013;1499. doi: 10.1007/s11095-007-9516-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11095-007-9516-9</ArticleId><ArticleId IdType="pmc">PMC2440933</ArticleId><ArticleId IdType="pubmed">18172579</ArticleId></ArticleIdList></Reference><Reference><Citation>Biancalana M., Koide S. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim. Biophys. Acta. 2010;1804:1405&#x2013;1412. doi: 10.1016/j.bbapap.2010.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2010.04.001</ArticleId><ArticleId IdType="pmc">PMC2880406</ArticleId><ArticleId IdType="pubmed">20399286</ArticleId></ArticleIdList></Reference><Reference><Citation>Amdursky N., Erez Y., Huppert D. Molecular rotors: What lies behind the high sensitivity of the thioflavin-T fluorescent marker. Acc. Chem. Res. 2012;45:1548&#x2013;1557. doi: 10.1021/ar300053p.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ar300053p</ArticleId><ArticleId IdType="pubmed">22738376</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuznetsova I.M., Sulatskaya A.I., Maskevich A.A., Uversky V.N., Turoverov K.K. High Fluorescence Anisotropy of Thioflavin T in Aqueous Solution Resulting from Its Molecular Rotor Nature. Anal. Chem. 2016;88:718&#x2013;724. doi: 10.1021/acs.analchem.5b02747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.5b02747</ArticleId><ArticleId IdType="pubmed">26637393</ArticleId></ArticleIdList></Reference><Reference><Citation>Gade Malmos K., Blancas-Mejia L.M., Weber B., Buchner J., Ramirez-Alvarado M., Naiki H., Otzen D. ThT 101: A primer on the use of thioflavin T to investigate amyloid formation. Amyloid. 2017;24:1&#x2013;16. doi: 10.1080/13506129.2017.1304905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13506129.2017.1304905</ArticleId><ArticleId IdType="pubmed">28393556</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue C., Lin T.Y., Chang D., Guo Z. Thioflavin T as an amyloid dye: Fibril quantification, optimal concentration and effect on aggregation. R. Soc. Open Sci. 2017;4:160696. doi: 10.1098/rsos.160696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsos.160696</ArticleId><ArticleId IdType="pmc">PMC5319338</ArticleId><ArticleId IdType="pubmed">28280572</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliyan A., Cook N.P., Marti A.A. Interrogating Amyloid Aggregates using Fluorescent Probes. Chem. Rev. 2019;119:11819&#x2013;11856. doi: 10.1021/acs.chemrev.9b00404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrev.9b00404</ArticleId><ArticleId IdType="pubmed">31675223</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Rodr&#xed;guez C., Rimola A., Rodr&#xed;guez-Santiago L., Ugliengo P., &#xc1;lvarez-Larena &#xc1;., Guti&#xe9;rrez-de-Ter&#xe1;n H., Sodupe M., Gonz&#xe1;lez-Duarte P. Crystal structure of thioflavin-T and its binding to amyloid fibrils: Insights at the molecular level. Chem. Commun. 2010;46:1156&#x2013;1158. doi: 10.1039/b912396b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/b912396b</ArticleId><ArticleId IdType="pubmed">20126745</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali-Torres J., Rimola A., Rodr&#xed;guez-Rodr&#xed;guez C., Rodr&#xed;guez-Santiago L., Sodupe M. Insights on the binding of Thioflavin derivative markers to amyloid-like fibril models from quantum chemical calculations. J. Phys. Chem. B. 2013;117:6674&#x2013;6680. doi: 10.1021/jp402807g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jp402807g</ArticleId><ArticleId IdType="pubmed">23662608</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuang G., Murugan N.A., Tu Y., Nordberg A., &#xc5;gren H. Investigation of the Binding Profiles of AZD2184 and Thioflavin T with Amyloid-beta(1-42) Fibril by Molecular Docking and Molecular Dynamics Methods. J. Phys. Chem. B. 2015;119:11560&#x2013;11567. doi: 10.1021/acs.jpcb.5b05964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpcb.5b05964</ArticleId><ArticleId IdType="pubmed">26266837</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaban H.A., Valades-Cruz C.A., Savatier J., Brasselet S. Polarized super-resolution structural imaging inside amyloid fibrils using Thioflavine T. Sci. Rep. 2017;7:12482. doi: 10.1038/s41598-017-12864-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-12864-9</ArticleId><ArticleId IdType="pmc">PMC5624930</ArticleId><ArticleId IdType="pubmed">28970520</ArticleId></ArticleIdList></Reference><Reference><Citation>Frieg B., Gremer L., Heise H., Willbold D., Gohlke H. Binding modes of thioflavin T and Congo red to the fibril structure of amyloid-beta(1-42) Chem. Commun. 2020;56:7589&#x2013;7592. doi: 10.1039/D0CC01161D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D0CC01161D</ArticleId><ArticleId IdType="pubmed">32510059</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulatskaya A.I., Rychkov G.N., Sulatsky M.I., Mikhailova E.V., Melnikova N.M., Andozhskaya V.S., Kuznetsova I.M., Turoverov K.K. New Evidence on a Distinction between A beta 40 and A beta 42 Amyloids: Thioflavin T Binding Modes, Clustering Tendency, Degradation Resistance, and Cross-Seeding. Int. J. Mol. Sci. 2022;23:5513. doi: 10.3390/ijms23105513.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23105513</ArticleId><ArticleId IdType="pmc">PMC9141448</ArticleId><ArticleId IdType="pubmed">35628325</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulatskaya A.I., Kuznetsova I.M., Belousov M.V., Bondarev S.A., Zhouravleva G.A., Turoverov K.K. Stoichiometry and Affinity of Thioflavin T Binding to Sup35p Amyloid Fibrils. PLoS ONE. 2016;11:e0156314. doi: 10.1371/journal.pone.0156314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0156314</ArticleId><ArticleId IdType="pmc">PMC4882037</ArticleId><ArticleId IdType="pubmed">27228180</ArticleId></ArticleIdList></Reference><Reference><Citation>Chisholm T.S., Hunter C.A. A closer look at amyloid ligands, and what they tell us about protein aggregates. Chem. Soc. Rev. 2024;53:1354&#x2013;1374. doi: 10.1039/D3CS00518F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D3CS00518F</ArticleId><ArticleId IdType="pubmed">38116736</ArticleId></ArticleIdList></Reference><Reference><Citation>Harel M., Sonoda L.K., Silman I., Sussman J.L., Rosenberry T.L. Crystal structure of thioflavin T bound to the peripheral site of Torpedo californica acetylcholinesterase reveals how thioflavin T acts as a sensitive fluorescent reporter of ligand binding to the acylation site. J. Am. Chem. Soc. 2008;130:7856&#x2013;7861. doi: 10.1021/ja7109822.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja7109822</ArticleId><ArticleId IdType="pmc">PMC3923376</ArticleId><ArticleId IdType="pubmed">18512913</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudson S.A., Ecroyd H., Kee T.W., Carver J.A. The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds. FEBS J. 2009;276:5960&#x2013;5972. doi: 10.1111/j.1742-4658.2009.07307.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2009.07307.x</ArticleId><ArticleId IdType="pubmed">19754881</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindberg D.J., Wranne M.S., Gilbert Gatty M., Westerlund F., Esbj&#xf6;rner E.K. Steady-state and time-resolved Thioflavin-T fluorescence can report on morphological differences in amyloid fibrils formed by Abeta(1-40) and Abeta(1-42) Biochem. Biophys. Res. Commun. 2015;458:418&#x2013;423. doi: 10.1016/j.bbrc.2015.01.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2015.01.132</ArticleId><ArticleId IdType="pubmed">25660454</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson K.P.R., &#xc5;slund A., Berg I., Nystr&#xf6;m S., Konradsson P., Herland A., Ingan&#xe4;s O., Stabo-Eeg F., Lindgren M., Westermark G.T., et al. Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer&#x2019;s disease using novel luminescent probes. ACS Chem. Biol. 2007;2:553&#x2013;560. doi: 10.1021/cb700116u.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cb700116u</ArticleId><ArticleId IdType="pubmed">17672509</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson K.P.R., Ikenberg K., &#xc5;slund A., Fransson S., Konradsson P., R&#xf6;cken C., Moch H., Aguzzi A. Structural typing of systemic amyloidoses by luminescent-conjugated polymer spectroscopy. Am. J. Pathol. 2010;176:563&#x2013;574. doi: 10.2353/ajpath.2010.080797.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2010.080797</ArticleId><ArticleId IdType="pmc">PMC2808065</ArticleId><ArticleId IdType="pubmed">20035056</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc5;slund A., Herland A., Hammarstr&#xf6;m P., Nilsson K.P.R., Jonsson B.H., Ingan&#xe4;s O., Konradsson P. Studies of luminescent conjugated polythiophene derivatives: Enhanced spectral discrimination of protein conformational states. Bioconjug. Chem. 2007;18:1860&#x2013;1868. doi: 10.1021/bc700180g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bc700180g</ArticleId><ArticleId IdType="pubmed">17939727</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingstedt T., &#xc5;slund A., Simon R.A., Johansson L.B.G., Mason J.J., Nystr&#xf6;m S., Hammarstr&#xf6;m P., Nilsson K.P.R. Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates. Org. Biomol. Chem. 2011;9:8356&#x2013;8370. doi: 10.1039/c1ob05637a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c1ob05637a</ArticleId><ArticleId IdType="pmc">PMC3326384</ArticleId><ArticleId IdType="pubmed">22051883</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingstedt T., Shirani H., &#xc5;slund K.O.A., Cairns N.J., Sigurdson C.J., Goedert M., Nilsson K.P.R. The structural basis for optimal performance of oligothiophene-based fluorescent amyloid ligands: Conformational flexibility is essential for spectral assignment of a diversity of protein aggregates. Chemistry. 2013;19:10179&#x2013;10192. doi: 10.1002/chem.201301463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/chem.201301463</ArticleId><ArticleId IdType="pmc">PMC3884759</ArticleId><ArticleId IdType="pubmed">23780508</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon R.A., Shirani H., &#xc5;slund K.O.A., B&#xe4;ck M., Haroutunian V., Gandy S., Nilsson K.P.R. Pentameric thiophene-based ligands that spectrally discriminate amyloid-beta and tau aggregates display distinct solvatochromism and viscosity-induced spectral shifts. Chemistry. 2014;20:12537&#x2013;12543. doi: 10.1002/chem.201402890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/chem.201402890</ArticleId><ArticleId IdType="pmc">PMC4221846</ArticleId><ArticleId IdType="pubmed">25111601</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesterov E.E., Skoch J., Hyman B.T., Klunk W.E., Bacskai B.J., Swager T.M. In vivo optical Imaging of amyloid aggregates in brain: Design of fluorescent markers. Angew. Chem. Int. Ed. Engl. 2005;44:5452&#x2013;5456. doi: 10.1002/anie.200500845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.200500845</ArticleId><ArticleId IdType="pubmed">16059955</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae S., Lim E., Hwang D., Huh H., Kim S.K. Torsion-dependent fluorescence switching of amyloid-binding dye NIAD-4. Chem. Phys. Lett. 2015;633:109&#x2013;113. doi: 10.1016/j.cplett.2015.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cplett.2015.05.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandenburg E., von Berlepsch H., Koksch B. Specific in situ discrimination of amyloid fibrils versus alpha-helical fibres by the fluorophore NIAD-4. Mol. Biosyst. 2012;8:557&#x2013;564. doi: 10.1039/C1MB05370A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C1MB05370A</ArticleId><ArticleId IdType="pubmed">22116468</ArticleId></ArticleIdList></Reference><Reference><Citation>Staderini M., Martin M.A., Bolognesi M.L., Men&#xe9;ndez J.C. Imaging of beta-amyloid plaques by near infrared fluorescent tracers: A new frontier for chemical neuroscience. Chem. Soc. Rev. 2015;44:1807&#x2013;1819. doi: 10.1039/C4CS00337C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C4CS00337C</ArticleId><ArticleId IdType="pubmed">25622714</ArticleId></ArticleIdList></Reference><Reference><Citation>Peccati F., Pantaleone S., Solans-Monfort X., Sodupe M. Fluorescent Markers for Amyloid-beta Detection: Computational Insights. Isr. J. Chem. 2017;57:686&#x2013;698. doi: 10.1002/ijch.201600114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijch.201600114</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Yang Y., Li C., Liu Y. The influence of hydrogen bonds on NIAD-4 for use in the optical imaging of amyloid fibrils. Phys. Chem. Chem. Phys. 2017;19:15849&#x2013;15855. doi: 10.1039/C7CP02268A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C7CP02268A</ArticleId><ArticleId IdType="pubmed">28585952</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu H., Cui M. Fluorescent Imaging of Amyloid-beta Deposits in Brain: An Overview of Probe Development and a Highlight of the Applications for In Vivo Imaging. Curr. Med. Chem. 2018;25:2736&#x2013;2759. doi: 10.2174/0929867325666180214110024.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867325666180214110024</ArticleId><ArticleId IdType="pubmed">29446721</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyasi Y.I., Pang Y.P., Li X.R., Gu J.X., Cheng X.J., Liu J., Xu T., Liu Y. Biological applications of near infrared fluorescence dye probes in monitoring Alzheimer&#x2019;s disease. Eur. J. Med. Chem. 2020;187:111982. doi: 10.1016/j.ejmech.2019.111982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2019.111982</ArticleId><ArticleId IdType="pubmed">31877538</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng C., Wang X., Li Y., Li H.-W., Wong M.S. Versatile fluorescent probes for near-infrared imaging of amyloid-beta species in Alzheimer&#x2019;s disease mouse model. J. Mater. Chem. B. 2022;7:1986&#x2013;1995. doi: 10.1039/C9TB00161A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C9TB00161A</ArticleId><ArticleId IdType="pubmed">32254802</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Mu X.Y., Yang J., Liang Y.Y., Zhang X.D., Ming D. Brain imaging with near-infrared fluorophores. Coord. Chem. Rev. 2019;380:550&#x2013;571. doi: 10.1016/j.ccr.2018.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccr.2018.11.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Mbotwe S., Bester J., Robinson C.J., Kell D.B. Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide. J. R. Soc. Interface. 2016;123:20160539. doi: 10.1098/rsif.2016.0539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2016.0539</ArticleId><ArticleId IdType="pmc">PMC5046953</ArticleId><ArticleId IdType="pubmed">27605168</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Page M.J., Hendricks L., Nkosi N.B., Benson S.R., Kell D.B. Both lipopolysaccharide and lipoteichoic acids potently induce anomalous fibrin amyloid formation: Assessment with novel Amytracker&#x2122; stains. J. R. Soc. Interface. 2018;15:20170941. doi: 10.1098/rsif.2017.0941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2017.0941</ArticleId><ArticleId IdType="pmc">PMC5832738</ArticleId><ArticleId IdType="pubmed">29445039</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Page M.J., Engelbrecht L., Ellis G.C., Kell D.B. Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains. Cardiovasc. Diabetol. 2017;16:141. doi: 10.1186/s12933-017-0624-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-017-0624-5</ArticleId><ArticleId IdType="pmc">PMC5668975</ArticleId><ArticleId IdType="pubmed">29096623</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Lourens P.J., Steenkamp J., Kell D.B. Prevalence of readily detected amyloid blood clots in &#x2018;unclotted&#x2019; Type 2 Diabetes Mellitus and COVID-19 plasma: A preliminary report. Cardiovasc. Diabetol. 2020;19:193. doi: 10.1186/s12933-020-01165-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-020-01165-7</ArticleId><ArticleId IdType="pmc">PMC7670290</ArticleId><ArticleId IdType="pubmed">33203441</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Laubscher G.J., Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: Origins and therapeutic implications. Biochem. J. 2022;479:537&#x2013;559. doi: 10.1042/BCJ20220016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Kotze M.J., Oladejo S., Watson L.R., Rajaratnam K., Watson B.W., Kell D.B. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/ Post-Acute Sequelae of COVID-19 (PASC) Cardiovasc. Diabetol. 2022;21:148. doi: 10.1186/s12933-022-01579-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Khan M.A., Putrino D., Woodcock A., Kell D.B., Pretorius E. Long COVID: Pathophysiological factors and abnormal coagulation. Trends Endocrinol. Metab. 2023;34:321&#x2013;344. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Laubscher G.J., Khan M.A., Kell D.B., Pretorius E. Accelerating discovery: A novel flow cytometric method for detecting fibrin(ogen) amyloid microclots using long COVID as a model. Heliyon. 2023;9:e19605. doi: 10.1016/j.heliyon.2023.e19605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e19605</ArticleId><ArticleId IdType="pmc">PMC10558872</ArticleId><ArticleId IdType="pubmed">37809592</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Khan M.A., Kane B., Lip G.Y.H., Pretorius E. Possible role of fibrinaloid microclots in Postural Orthostatic Tachycardia Syndrome (POTS): Focus on Long COVID. J. Pers. Med. 2024;14:170. doi: 10.3390/jpm14020170.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm14020170</ArticleId><ArticleId IdType="pmc">PMC10890060</ArticleId><ArticleId IdType="pubmed">38392604</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Kell D.B. A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations. Semin. Thromb. Hemost. 2024;50:537&#x2013;551. doi: 10.1055/s-0043-1774796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0043-1774796</ArticleId><ArticleId IdType="pmc">PMC11105946</ArticleId><ArticleId IdType="pubmed">37748515</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalton C.F., de Oliveira M.I.R., Stafford P., Peake N., Kane B., Higham A., Singh D., Jackson N., Davies H., Price D., et al. Increased fibrinaloid microclot counts in platelet-poor plasma are associated with Long COVID. medRxiv. 2024 doi: 10.1101/2024.04.04.24305318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.04.04.24305318</ArticleId></ArticleIdList></Reference><Reference><Citation>Schofield J., Abrams S.T., Jenkins R., Lane S., Wang G., Toh C.H. Amyloid-fibrinogen aggregates (&#x201c;microclots&#x201d;) predict risks of Disseminated Intravascular Coagulation and mortality. Blood Adv. 2024;8:2499&#x2013;2508. doi: 10.1182/bloodadvances.2023012473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2023012473</ArticleId><ArticleId IdType="pmc">PMC11131067</ArticleId><ArticleId IdType="pubmed">38507683</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H., Fu Y., Zhan S., Luo Y. Alpha(E)C, the C-terminal extension of fibrinogen, has chaperone-like activity. Biochemistry. 2009;48:3967&#x2013;3976. doi: 10.1021/bi900015n.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi900015n</ArticleId><ArticleId IdType="pubmed">19284787</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H., Fu Y., Cui Y., He Y., Zeng X., Ploplis V.A., Castellino F.J., Luo Y. Fibrinogen has chaperone-like activity. Biochem. Biophys. Res. Commun. 2009;378:662&#x2013;667. doi: 10.1016/j.bbrc.2008.11.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2008.11.112</ArticleId><ArticleId IdType="pmc">PMC2663026</ArticleId><ArticleId IdType="pubmed">19059206</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto N., Chatani E. Multistep growth of amyloid intermediates and its inhibition toward exploring therapeutic way: A case study using insulin B chain and fibrinogen. Biophys. Physicobiol. 2022;19:e190017. doi: 10.2142/biophysico.bppb-v19.0017.</Citation><ArticleIdList><ArticleId IdType="doi">10.2142/biophysico.bppb-v19.0017</ArticleId><ArticleId IdType="pmc">PMC9173859</ArticleId><ArticleId IdType="pubmed">35797403</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillmore J.D., Lachmann H.J., Wechalekar A., Hawkins P.N. Hereditary fibrinogen A alpha-chain amyloidosis: Clinical phenotype and role of liver transplantation. Blood. 2010;115:4313. doi: 10.1182/blood-2010-01-261750. author reply 4314&#x2013;4315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2010-01-261750</ArticleId><ArticleId IdType="pubmed">20508170</ArticleId></ArticleIdList></Reference><Reference><Citation>Stangou A.J., Banner N.R., Hendry B.M., Rela M., Portmann B., Wendon J., Monaghan M., Maccarthy P., Buxton-Thomas M., Mathias C.J., et al. Hereditary fibrinogen A alpha-chain amyloidosis: Phenotypic characterization of a systemic disease and the role of liver transplantation. Blood. 2010;115:2998&#x2013;3007. doi: 10.1182/blood-2009-06-223792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2009-06-223792</ArticleId><ArticleId IdType="pubmed">19633201</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman J., Dogan A. Fibrinogen alpha amyloidosis: Insights from proteomics. Expert. Rev. Proteom. 2019;16:783&#x2013;793. doi: 10.1080/14789450.2019.1659137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14789450.2019.1659137</ArticleId><ArticleId IdType="pmc">PMC6788741</ArticleId><ArticleId IdType="pubmed">31443619</ArticleId></ArticleIdList></Reference><Reference><Citation>Overoye-Chan K., Koerner S., Looby R.J., Kolodziej A.F., Zech S.G., Deng Q., Chasse J.M., McMurry T.J., Caravan P. EP-2104R: A fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus. J. Am. Chem. Soc. 2008;130:6025&#x2013;6039. doi: 10.1021/ja800834y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja800834y</ArticleId><ArticleId IdType="pubmed">18393503</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara T., Bhayana B., Thompson B., Kessinger C.W., Khatri A., McCarthy J.R., Weissleder R., Lin C.P., Tearney G.J., Jaffer F.A. Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence. JACC Cardiovasc. Imaging. 2012;5:607&#x2013;615. doi: 10.1016/j.jcmg.2012.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2012.01.017</ArticleId><ArticleId IdType="pmc">PMC3376390</ArticleId><ArticleId IdType="pubmed">22698530</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss N., Schenk B., Bachler M., Solomon C., Fries D., Hermann M. FITC-linked Fibrin-Binding Peptide and real-time live confocal microscopy as a novel tool to visualize fibrin(ogen) in coagulation. J. Clin. Transl. Res. 2017;3:276&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6410668</ArticleId><ArticleId IdType="pubmed">30873479</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambaran R.N., Serpell L.C. Amyloid fibrils: Abnormal protein assembly. Prion. 2008;2:112&#x2013;117. doi: 10.4161/pri.2.3.7488.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.2.3.7488</ArticleId><ArticleId IdType="pmc">PMC2634529</ArticleId><ArticleId IdType="pubmed">19158505</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S., Brunden K.R., Trojanowski J.Q., Lee V.M. Characterization of tau fibrillization in vitro. Alzheimer&#x2019;s Dement. 2010;6:110&#x2013;117. doi: 10.1016/j.jalz.2009.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2009.06.002</ArticleId><ArticleId IdType="pmc">PMC2842604</ArticleId><ArticleId IdType="pubmed">20298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenitsch H., Benetti F., Ramos A., Legname G., Requena J.R. SAXS structural study of PrP(Sc) reveals ~11 nm diameter of basic double intertwined fibers. Prion. 2013;7:496&#x2013;500. doi: 10.4161/pri.27190.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.27190</ArticleId><ArticleId IdType="pmc">PMC4201618</ArticleId><ArticleId IdType="pubmed">24247356</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Shi Y., Schweighauser M., Zhang X., Kotecha A., Murzin A.G., Garringer H.J., Cullinane P.W., Saito Y., Foroud T., et al. Structures of alpha-synuclein filaments from human brains with Lewy pathology. Nature. 2022;610:791&#x2013;795. doi: 10.1038/s41586-022-05319-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05319-3</ArticleId><ArticleId IdType="pmc">PMC7613749</ArticleId><ArticleId IdType="pubmed">36108674</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhavale D.D., Barclay A.M., Borcik C.G., Basore K., Berthold D.A., Gordon I.R., Liu J., Milchberg M.H., O&#x2019;Shea J.Y., Rau M.J., et al. Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue. Nat. Commun. 2024;15:2750. doi: 10.1038/s41467-024-46832-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-46832-5</ArticleId><ArticleId IdType="pmc">PMC10980826</ArticleId><ArticleId IdType="pubmed">38553463</ArticleId></ArticleIdList></Reference><Reference><Citation>He S., He X., Liu L., Zhang W., Yu L., Deng Z., Feiyi Z., Mo S., Fan Y., Zhao X., et al. The Structural Understanding of Transthyretin Misfolding and the Inspired Drug Approaches for the Treatment of Heart Failure Associated with Transthyretin Amyloidosis. Front. Pharmacol. 2021;12:628184. doi: 10.3389/fphar.2021.628184.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.628184</ArticleId><ArticleId IdType="pmc">PMC7930814</ArticleId><ArticleId IdType="pubmed">33679409</ArticleId></ArticleIdList></Reference><Reference><Citation>Yermolenko I.S., Lishko V.K., Ugarova T.P., Magonov S.N. High-resolution visualization of fibrinogen molecules and fibrin fibers with atomic force microscopy. Biomacromolecules. 2011;12:370&#x2013;379. doi: 10.1021/bm101122g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bm101122g</ArticleId><ArticleId IdType="pubmed">21192636</ArticleId></ArticleIdList></Reference><Reference><Citation>Blinc A., Magdi&#x10d; J., Fric J., Mu&#x161;evi&#x10d; Atomic force microscopy of fibrin networks and plasma clots during fibrinolysis. Fibrinolysis Proteolysis. 2000;14:288&#x2013;299. doi: 10.1054/fipr.2000.0085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1054/fipr.2000.0085</ArticleId></ArticleIdList></Reference><Reference><Citation>Collet J.P., Park D., Lesty C., Soria J., Soria C., Montalescot G., Weisel J.W. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: Dynamic and structural approaches by confocal microscopy. Arterioscler. Thromb. Vasc. Biol. 2000;20:1354&#x2013;1361. doi: 10.1161/01.ATV.20.5.1354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.20.5.1354</ArticleId><ArticleId IdType="pubmed">10807754</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Sigley J., Pieters M., Helms C.C., Nagaswami C., Weisel J.W., Guthold M. Fibrin Fiber Stiffness Is Strongly Affected by Fiber Diameter, but Not by Fibrinogen Glycation. Biophys. J. 2016;110:1400&#x2013;1410. doi: 10.1016/j.bpj.2016.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2016.02.021</ArticleId><ArticleId IdType="pmc">PMC4816776</ArticleId><ArticleId IdType="pubmed">27028649</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Sigley J., Baker S.R., Helms C.C., Kinney M.T., Pieters M., Brubaker P.H., Cubcciotti R., Guthold M. Nonuniform Internal Structure of Fibrin Fibers: Protein Density and Bond Density Strongly Decrease with Increasing Diameter. Biomed. Res. Int. 2017;2017:6385628. doi: 10.1155/2017/6385628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/6385628</ArticleId><ArticleId IdType="pmc">PMC5654258</ArticleId><ArticleId IdType="pubmed">29130043</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhmurov A., Protopopova A.D., Litvinov R.I., Zhukov P., Weisel J.W., Barsegov V. Atomic Structural Models of Fibrin Oligomers. Structure. 2018;26:857&#x2013;868.e854. doi: 10.1016/j.str.2018.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2018.04.005</ArticleId><ArticleId IdType="pmc">PMC6501597</ArticleId><ArticleId IdType="pubmed">29754827</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhmurov A., Kononova O., Litvinov R.I., Dima R.I., Barsegov V., Weisel J.W. Mechanical transition from alpha-helical coiled coils to beta-sheets in fibrin(ogen) J. Am. Chem. Soc. 2012;134:20396&#x2013;20402. doi: 10.1021/ja3076428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja3076428</ArticleId><ArticleId IdType="pmc">PMC3526676</ArticleId><ArticleId IdType="pubmed">22953986</ArticleId></ArticleIdList></Reference><Reference><Citation>Minin K.A., Zhmurov A., Marx K.A., Purohit P.K., Barsegov V. Dynamic Transition from alpha-Helices to beta-Sheets in Polypeptide Coiled-Coil Motifs. J. Am. Chem. Soc. 2017;139:16168&#x2013;16177. doi: 10.1021/jacs.7b06883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.7b06883</ArticleId><ArticleId IdType="pubmed">29043794</ArticleId></ArticleIdList></Reference><Reference><Citation>Risman R.A., Belcher H.A., Ramanujam R.K., Weisel J.W., Hudson N.E., Tutwiler V. Comprehensive Analysis of the Role of Fibrinogen and Thrombin in Clot Formation and Structure for Plasma and Purified Fibrinogen. Biomolecules. 2024;14:230. doi: 10.3390/biom14020230.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom14020230</ArticleId><ArticleId IdType="pmc">PMC10886591</ArticleId><ArticleId IdType="pubmed">38397467</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolberg A.S. Thrombin generation and fibrin clot structure. Blood Rev. 2007;21:131&#x2013;142. doi: 10.1016/j.blre.2006.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2006.11.001</ArticleId><ArticleId IdType="pubmed">17208341</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanepoel A.C., Lindeque B.G., Swart P.J., Abdool Z., Pretorius E. Estrogen causes ultrastructural changes of fibrin networks during the menstrual cycle: A qualitative investigation. Microsc. Res. Tech. 2014;77:594&#x2013;601. doi: 10.1002/jemt.22378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jemt.22378</ArticleId><ArticleId IdType="pubmed">24841871</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarro S., D&#xed;az-Caballero M., Peccati F., Rold&#xe1;n-Martin L., Sodupe M., Ventura S. Amyloid Fibrils Formed by Short Prion-Inspired Peptides Are Metalloenzymes. ACS Nano. 2023;17:16968&#x2013;16979. doi: 10.1021/acsnano.3c04164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.3c04164</ArticleId><ArticleId IdType="pmc">PMC10510724</ArticleId><ArticleId IdType="pubmed">37647583</ArticleId></ArticleIdList></Reference><Reference><Citation>Usuelli M., Ruzzi V., Buzzaccaro S., Nystr&#xf6;m G., Piazza R., Mezzenga R. Unraveling gelation kinetics, arrested dynamics and relaxation phenomena in filamentous colloids by photon correlation imaging. Soft Matter. 2022;18:5632&#x2013;5644. doi: 10.1039/D1SM01578H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D1SM01578H</ArticleId><ArticleId IdType="pubmed">35861104</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurniawan N.A., van Kempen T.H.S., Sonneveld S., Rosalina T.T., Vos B.E., Jansen K.A., Peters G.W.M., van de Vosse F.N., Koenderink G.H. Buffers Strongly Modulate Fibrin Self-Assembly into Fibrous Networks. Langmuir. 2017;33:6342&#x2013;6352. doi: 10.1021/acs.langmuir.7b00527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.langmuir.7b00527</ArticleId><ArticleId IdType="pmc">PMC5489959</ArticleId><ArticleId IdType="pubmed">28558246</ArticleId></ArticleIdList></Reference><Reference><Citation>Uversky V.N., Li J., Bower K., Fink A.L. Synergistic effects of pesticides and metals on the fibrillation of alpha-synuclein: Implications for Parkinson&#x2019;s disease. Neurotoxicology. 2002;23:527&#x2013;536. doi: 10.1016/S0161-813X(02)00067-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0161-813X(02)00067-0</ArticleId><ArticleId IdType="pubmed">12428725</ArticleId></ArticleIdList></Reference><Reference><Citation>Villaverde A., Carri&#xf3; M.M. Protein aggregation in recombinant bacteria: Biological role of inclusion bodies. Biotechnol. Lett. 2003;25:1385&#x2013;1395. doi: 10.1023/A:1025024104862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1025024104862</ArticleId><ArticleId IdType="pubmed">14514038</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventura S., Villaverde A. Protein quality in bacterial inclusion bodies. Trends Biotechnol. 2006;24:179&#x2013;185. doi: 10.1016/j.tibtech.2006.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibtech.2006.02.007</ArticleId><ArticleId IdType="pubmed">16503059</ArticleId></ArticleIdList></Reference><Reference><Citation>Hockney R.C. Recent developments in heterologous protein production in Escherichia coli. Trends Biotechnol. 1994;12:456&#x2013;463. doi: 10.1016/0167-7799(94)90021-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0167-7799(94)90021-3</ArticleId><ArticleId IdType="pubmed">7765545</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xe5;llberg F., Sundstr&#xf6;m H., Ledung E., Hewitt C.J., Enfors S.O. Monitoring and quantification of inclusion body formation in Escherichia coli by multi-parameter flow cytometry. Biotechnol. Lett. 2005;27:919&#x2013;926. doi: 10.1007/s10529-005-7184-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10529-005-7184-6</ArticleId><ArticleId IdType="pubmed">16091887</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.J., Jung K.H. Modulation of the tendency towards inclusion body formation of recombinant protein by the addition of glucose in the araBAD promoter system of Escherichia coli. J. Microbiol. Biotechnol. 2007;17:1898&#x2013;1903.</Citation><ArticleIdList><ArticleId IdType="pubmed">18092479</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopp J., Spadiut O. Inclusion Bodies: Status Quo and Perspectives. Methods Mol. Biol. 2023;2617:1&#x2013;13. doi: 10.1007/978-1-0716-2930-7_1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-2930-7_1</ArticleId><ArticleId IdType="pubmed">36656513</ArticleId></ArticleIdList></Reference><Reference><Citation>Kachhawaha K., Singh S., Joshi K., Nain P., Singh S.K. Bioprocessing of recombinant proteins from Escherichia coli inclusion bodies: Insights from structure-function relationship for novel applications. Prep. Biochem. Biotechnol. 2023;53:728&#x2013;752. doi: 10.1080/10826068.2022.2155835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10826068.2022.2155835</ArticleId><ArticleId IdType="pubmed">36534636</ArticleId></ArticleIdList></Reference><Reference><Citation>Housmans J.A.J., Wu G., Schymkowitz J., Rousseau F. A guide to studying protein aggregation. FEBS J. 2023;290:554&#x2013;583. doi: 10.1111/febs.16312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.16312</ArticleId><ArticleId IdType="pubmed">34862849</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Maji S.K., Sawaya M.R., Eisenberg D., Riek R. Bacterial inclusion bodies contain amyloid-like structure. PLoS Biol. 2008;6:e195. doi: 10.1371/journal.pbio.0060195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0060195</ArticleId><ArticleId IdType="pmc">PMC2494559</ArticleId><ArticleId IdType="pubmed">18684013</ArticleId></ArticleIdList></Reference><Reference><Citation>de Groot N.S., Sabate R., Ventura S. Amyloids in bacterial inclusion bodies. Trends Biochem. Sci. 2009;34:408&#x2013;416. doi: 10.1016/j.tibs.2009.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2009.03.009</ArticleId><ArticleId IdType="pubmed">19647433</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Fruit&#xf3;s E., Sabate R., de Groot N.S., Villaverde A., Ventura S. Biological role of bacterial inclusion bodies: A model for amyloid aggregation. FEBS J. 2011;278:2419&#x2013;2427. doi: 10.1111/j.1742-4658.2011.08165.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2011.08165.x</ArticleId><ArticleId IdType="pubmed">21569209</ArticleId></ArticleIdList></Reference><Reference><Citation>de Marco A., Ferrer-Miralles N., Garcia-Fruit&#xf3;s E., Mitraki A., Peternel S., Rinas U., Trujillo-Rold&#xe1;n M.A., Valdez-Cruz N.A., V&#xe1;zquez E., Villaverde A. Bacterial inclusion bodies are industrially exploitable amyloids. FEMS Microbiol. Rev. 2019;43:53&#x2013;72. doi: 10.1093/femsre/fuy038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femsre/fuy038</ArticleId><ArticleId IdType="pubmed">30357330</ArticleId></ArticleIdList></Reference><Reference><Citation>Carratal&#xe1; J.V., Cisneros A., Hellman E., Villaverde A., Ferrer-Miralles N. Insoluble proteins catch heterologous soluble proteins into inclusion bodies by intermolecular interaction of aggregating peptides. Microb. Cell Fact. 2021;20:30. doi: 10.1186/s12934-021-01524-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12934-021-01524-3</ArticleId><ArticleId IdType="pmc">PMC7852131</ArticleId><ArticleId IdType="pubmed">33531005</ArticleId></ArticleIdList></Reference><Reference><Citation>Cano-Garrido O., Rodr&#xed;guez-Carmona E., D&#xed;ez-Gil C., V&#xe1;zquez E., Elizondo E., Cubarsi R., Seras-Franzoso J., Corchero J.L., Rinas U., Ratera I., et al. Supramolecular organization of protein-releasing functional amyloids solved in bacterial inclusion bodies. Acta Biomater. 2013;9:6134&#x2013;6142. doi: 10.1016/j.actbio.2012.11.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.actbio.2012.11.033</ArticleId><ArticleId IdType="pubmed">23220450</ArticleId></ArticleIdList></Reference><Reference><Citation>Villaverde A., Corchero J.L., Seras-Franzoso J., Garcia-Fruitos E. Functional protein aggregates: Just the tip of the iceberg. Nanomedicine. 2015;10:2881&#x2013;2891. doi: 10.2217/nnm.15.125.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nnm.15.125</ArticleId><ArticleId IdType="pubmed">26370294</ArticleId></ArticleIdList></Reference><Reference><Citation>Hrabarova E., Belkova M., Koszagova R., Nahalka J. Pull-Down Into Active Inclusion Bodies and Their Application in the Detection of (Poly)-Phosphates and Metal-Ions. Front. Bioeng. Biotechnol. 2022;10:833192. doi: 10.3389/fbioe.2022.833192.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbioe.2022.833192</ArticleId><ArticleId IdType="pmc">PMC8921494</ArticleId><ArticleId IdType="pubmed">35299638</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiti F., Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006;75:333&#x2013;366. doi: 10.1146/annurev.biochem.75.101304.123901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.75.101304.123901</ArticleId><ArticleId IdType="pubmed">16756495</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson C.M. Protein folding and misfolding. Nature. 2003;426:884&#x2013;890. doi: 10.1038/nature02261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02261</ArticleId><ArticleId IdType="pubmed">14685248</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowles T.P.J., Vendruscolo M., Dobson C.M. The amyloid state and its association with protein misfolding diseases. Nat. Rev. Mol. Cell Biol. 2014;15:384&#x2013;396. doi: 10.1038/nrm3810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3810</ArticleId><ArticleId IdType="pubmed">24854788</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadanza M.G., Jackson M.P., Hewitt E.W., Ranson N.A., Radford S.E. A new era for understanding amyloid structures and disease. Nat. Rev. Mol. Cell Biol. 2018;19:755&#x2013;773. doi: 10.1038/s41580-018-0060-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-018-0060-8</ArticleId><ArticleId IdType="pubmed">30237470</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh D., Biswas A., Radhakrishna M. Advanced computational approaches to understand protein aggregation. Biophys. Rev. 2024;5:021302. doi: 10.1063/5.0180691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/5.0180691</ArticleId><ArticleId IdType="pmc">PMC11045254</ArticleId><ArticleId IdType="pubmed">38681860</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauser C.A.E., Maurer-Stroh S., Martins I.C. Amyloid-based nanosensors and nanodevices. Chem. Soc. Rev. 2014;43:5326&#x2013;5345. doi: 10.1039/C4CS00082J.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C4CS00082J</ArticleId><ArticleId IdType="pubmed">24781248</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke P.C., Zhou R., Serpell L.C., Riek R., Knowles T.P.J., Lashuel H.A., Gazit E., Hamley I.W., Davis T.P., Fandrich M., et al. Half a century of amyloids: Past, present and future. Chem. Soc. Rev. 2020;49:5473&#x2013;5509. doi: 10.1039/C9CS00199A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C9CS00199A</ArticleId><ArticleId IdType="pmc">PMC7445747</ArticleId><ArticleId IdType="pubmed">32632432</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris K.L., Serpell L.C. X-ray fibre diffraction studies of amyloid fibrils. Methods Mol. Biol. 2012;849:121&#x2013;135. doi: 10.1007/978-1-61779-551-0_9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-61779-551-0_9</ArticleId><ArticleId IdType="pubmed">22528087</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Garawi Z.S., Morris K.L., Marshall K.E., Eichler J., Serpell L.C. The diversity and utility of amyloid fibrils formed by short amyloidogenic peptides. Interface Focus. 2017;7:20170027. doi: 10.1098/rsfs.2017.0027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsfs.2017.0027</ArticleId><ArticleId IdType="pmc">PMC5665797</ArticleId><ArticleId IdType="pubmed">29147557</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpell L.C., Sunde M., Benson M.D., Tennent G.A., Pepys M.B., Fraser P.E. The protofilament substructure of amyloid fibrils. J. Mol. Biol. 2000;300:1033&#x2013;1039. doi: 10.1006/jmbi.2000.3908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.2000.3908</ArticleId><ArticleId IdType="pubmed">10903851</ArticleId></ArticleIdList></Reference><Reference><Citation>Makin O.S., Atkins E., Sikorski P., Johansson J., Serpell L.C. Molecular basis for amyloid fibril formation and stability. Proc. Natl. Acad. Sci. USA. 2005;102:315&#x2013;320. doi: 10.1073/pnas.0406847102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0406847102</ArticleId><ArticleId IdType="pmc">PMC544296</ArticleId><ArticleId IdType="pubmed">15630094</ArticleId></ArticleIdList></Reference><Reference><Citation>Cremades N., Dobson C.M. The contribution of biophysical and structural studies of protein self-assembly to the design of therapeutic strategies for amyloid diseases. Neurobiol. Dis. 2018;109:178&#x2013;190. doi: 10.1016/j.nbd.2017.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2017.07.009</ArticleId><ArticleId IdType="pubmed">28709995</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunde M., Blake C.C.F. From the globular to the fibrous state: Protein structure and structural conversion in amyloid formation. Q. Rev. Biophys. 1998;31:1&#x2013;39. doi: 10.1017/S0033583598003400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033583598003400</ArticleId><ArticleId IdType="pubmed">9717197</ArticleId></ArticleIdList></Reference><Reference><Citation>Petkova A.T., Leapman R.D., Guo Z., Yau W.M., Mattson M.P., Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer&#x2019;s beta-amyloid fibrils. Science. 2005;307:262&#x2013;265. doi: 10.1126/science.1105850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1105850</ArticleId><ArticleId IdType="pubmed">15653506</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier B.H., B&#xf6;ckmann A. The structure of fibrils from &#x2018;misfolded&#x2019; proteins. Curr. Opin. Struct. Biol. 2015;30:43&#x2013;49. doi: 10.1016/j.sbi.2014.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2014.12.001</ArticleId><ArticleId IdType="pubmed">25544255</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutter L., Serpell C.J., Tuite M.F., Xue W.F. The molecular lifecycle of amyloid&#x2014;Mechanism of assembly, mesoscopic organisation, polymorphism, suprastructures, and biological consequences. Biochim. Biophys. Acta Proteins Proteom. 2019;1867:140257. doi: 10.1016/j.bbapap.2019.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2019.07.010</ArticleId><ArticleId IdType="pubmed">31352057</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefani M. Structural polymorphism of amyloid oligomers and fibrils underlies different fibrillization pathways: Immunogenicity and cytotoxicity. Curr. Protein Pept. Sci. 2010;11:343&#x2013;354. doi: 10.2174/138920310791330631.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920310791330631</ArticleId><ArticleId IdType="pubmed">20423295</ArticleId></ArticleIdList></Reference><Reference><Citation>Tycko R. Physical and structural basis for polymorphism in amyloid fibrils. Protein Sci. 2014;23:1528&#x2013;1539. doi: 10.1002/pro.2544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.2544</ArticleId><ArticleId IdType="pmc">PMC4241104</ArticleId><ArticleId IdType="pubmed">25179159</ArticleId></ArticleIdList></Reference><Reference><Citation>Riek R. The Three-Dimensional Structures of Amyloids. Cold Spring Harb. Perspect. Biol. 2017;9:a023572. doi: 10.1101/cshperspect.a023572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a023572</ArticleId><ArticleId IdType="pmc">PMC5287077</ArticleId><ArticleId IdType="pubmed">27793967</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson M., Xu Y., Thacker D., Taylor A.I.P., Fisher D.G., Gallardo R.U., Radford S.E., Ranson N.A. Structural evolution of fibril polymorphs during amyloid assembly. Cell. 2023;186:5798&#x2013;5811.e5726. doi: 10.1016/j.cell.2023.11.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.11.025</ArticleId><ArticleId IdType="pubmed">38134875</ArticleId></ArticleIdList></Reference><Reference><Citation>Guenther E.L., Ge P., Trinh H., Sawaya M.R., Cascio D., Boyer D.R., Gonen T., Zhou Z.H., Eisenberg D.S. Atomic-level evidence for packing and positional amyloid polymorphism by segment from TDP-43 RRM2. Nat. Struct. Mol. Biol. 2018;25:311&#x2013;319. doi: 10.1038/s41594-018-0045-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-018-0045-5</ArticleId><ArticleId IdType="pmc">PMC6056015</ArticleId><ArticleId IdType="pubmed">29531287</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermeier L., de Oliveira G.A.P., Dzwolak W., Silva J.L., Winter R. Exploring the polymorphism, conformational dynamics and function of amyloidogenic peptides and proteins by temperature and pressure modulation. Biophys. Chem. 2021;268:106506. doi: 10.1016/j.bpc.2020.106506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpc.2020.106506</ArticleId><ArticleId IdType="pubmed">33221697</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Liu C. Conformational strains of pathogenic amyloid proteins in neurodegenerative diseases. Nat. Rev. Neurosci. 2022;23:523&#x2013;534. doi: 10.1038/s41583-022-00603-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-022-00603-7</ArticleId><ArticleId IdType="pubmed">35637417</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Liu C. Molecular rules governing the structural polymorphism of amyloid fibrils in neurodegenerative diseases. Structure. 2023;31:1335&#x2013;1347. doi: 10.1016/j.str.2023.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2023.08.006</ArticleId><ArticleId IdType="pubmed">37657437</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor A.I.P., Staniforth R.A. General Principles Underpinning Amyloid Structure. Front. Neurosci. 2022;16:878869. doi: 10.3389/fnins.2022.878869.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.878869</ArticleId><ArticleId IdType="pmc">PMC9201691</ArticleId><ArticleId IdType="pubmed">35720732</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;vestam S., Li D., Wagstaff J.L., Kotecha A., Kimanius D., McLaughlin S.H., Murzin A.G., Freund S.M.V., Goedert M., Scheres S.H.W. Disease-specific tau filaments assemble via polymorphic intermediates. Nature. 2024;625:119&#x2013;125. doi: 10.1038/s41586-023-06788-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06788-w</ArticleId><ArticleId IdType="pmc">PMC10764278</ArticleId><ArticleId IdType="pubmed">38030728</ArticleId></ArticleIdList></Reference><Reference><Citation>Tycko R. Amyloid polymorphism: Structural basis and neurobiological relevance. Neuron. 2015;86:632&#x2013;645. doi: 10.1016/j.neuron.2015.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.03.017</ArticleId><ArticleId IdType="pmc">PMC4425266</ArticleId><ArticleId IdType="pubmed">25950632</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguzzi A., Calella A.M. Prions: Protein aggregation and infectious diseases. Physiol. Rev. 2009;89:1105&#x2013;1152. doi: 10.1152/physrev.00006.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00006.2009</ArticleId><ArticleId IdType="pubmed">19789378</ArticleId></ArticleIdList></Reference><Reference><Citation>Igel-Egalon A., B&#xe9;ringue V., Rezaei H., Sibille P. Prion Strains and Transmission Barrier Phenomena. Pathogens. 2018;7:5. doi: 10.3390/pathogens7010005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens7010005</ArticleId><ArticleId IdType="pmc">PMC5874731</ArticleId><ArticleId IdType="pubmed">29301257</ArticleId></ArticleIdList></Reference><Reference><Citation>Arifin M.I., Hannaoui S., Chang S.C., Thapa S., Schatzl H.M., Gilch S. Cervid Prion Protein Polymorphisms: Role in Chronic Wasting Disease Pathogenesis. Int. J. Mol. Sci. 2021;22:2271. doi: 10.3390/ijms22052271.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052271</ArticleId><ArticleId IdType="pmc">PMC7956812</ArticleId><ArticleId IdType="pubmed">33668798</ArticleId></ArticleIdList></Reference><Reference><Citation>Igel A., Fornara B., Rezaei H., B&#xe9;ringue V. Prion assemblies: Structural heterogeneity, mechanisms of formation, and role in species barrier. Cell Tissue Res. 2023;392:149&#x2013;166. doi: 10.1007/s00441-022-03700-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-022-03700-2</ArticleId><ArticleId IdType="pmc">PMC10113350</ArticleId><ArticleId IdType="pubmed">36399162</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoup D., Priola S.A. Cell biology of prion strains in vivo and in vitro. Cell Tissue Res. 2022;392:269&#x2013;283. doi: 10.1007/s00441-021-03572-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-021-03572-y</ArticleId><ArticleId IdType="pmc">PMC11249200</ArticleId><ArticleId IdType="pubmed">35107622</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguzzi A., Rajendran L. The transcellular spread of cytosolic amyloids, prions, and prionoids. Neuron. 2009;64:783&#x2013;790. doi: 10.1016/j.neuron.2009.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2009.12.016</ArticleId><ArticleId IdType="pubmed">20064386</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashe K.H., Aguzzi A. Prions, prionoids and pathogenic proteins in Alzheimer disease. Prion. 2013;7:55&#x2013;59. doi: 10.4161/pri.23061.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.23061</ArticleId><ArticleId IdType="pmc">PMC3609051</ArticleId><ArticleId IdType="pubmed">23208281</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosset P., Camu W., Raoul C., Mezghrani A. Prionoids in amyotrophic lateral sclerosis. Brain Commun. 2022;4:fcac145. doi: 10.1093/braincomms/fcac145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcac145</ArticleId><ArticleId IdType="pmc">PMC9242622</ArticleId><ArticleId IdType="pubmed">35783556</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafner Bratkovi&#x10d; I. Prions, prionoid complexes and amyloids: The bad, the good and something in between. Swiss Med. Wkly. 2017;147:w14424. doi: 10.4414/smw.2017.14424.</Citation><ArticleIdList><ArticleId IdType="doi">10.4414/smw.2017.14424</ArticleId><ArticleId IdType="pubmed">28421568</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells C., Brennan S.E., Keon M., Saksena N.K. Prionoid Proteins in the Pathogenesis of Neurodegenerative Diseases. Front. Mol. Neurosci. 2019;12:271. doi: 10.3389/fnmol.2019.00271.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00271</ArticleId><ArticleId IdType="pmc">PMC6861308</ArticleId><ArticleId IdType="pubmed">31780895</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F., Coquel A.S., Moreno-Del Alamo M., Chen P., Song X., Serrano A.M., Fernandez-Tresguerres M.E., Moreno-Diaz de la Espina S., Lindner A.B., Giraldo R. Direct assessment in bacteria of prionoid propagation and phenotype selection by Hsp70 chaperone. Mol. Microbiol. 2014;91:1070&#x2013;1087. doi: 10.1111/mmi.12518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/mmi.12518</ArticleId><ArticleId IdType="pubmed">24417419</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick A.W.P., Falcon B., He S., Murzin A.G., Murshudov G., Garringer H.J., Crowther R.A., Ghetti B., Goedert M., Scheres S.H.W. Cryo-EM structures of tau filaments from Alzheimer&#x2019;s disease. Nature. 2017;547:185&#x2013;190. doi: 10.1038/nature23002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature23002</ArticleId><ArticleId IdType="pmc">PMC5552202</ArticleId><ArticleId IdType="pubmed">28678775</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Liu C. Structural Diversity of Amyloid Fibrils and Advances in Their Structure Determination. Biochemistry. 2020;59:639&#x2013;646. doi: 10.1021/acs.biochem.9b01069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.9b01069</ArticleId><ArticleId IdType="pubmed">31967790</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzpatrick A.W., Saibil H.R. Cryo-EM of amyloid fibrils and cellular aggregates. Curr. Opin. Struct. Biol. 2019;58:34&#x2013;42. doi: 10.1016/j.sbi.2019.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2019.05.003</ArticleId><ArticleId IdType="pmc">PMC6778506</ArticleId><ArticleId IdType="pubmed">31200186</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowles T.P.J., Fitzpatrick A.W., Meehan S., Mott H.R., Vendruscolo M., Dobson C.M., Welland M.E. Role of intermolecular forces in defining material properties of protein nanofibrils. Science. 2007;318:1900&#x2013;1903. doi: 10.1126/science.1150057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1150057</ArticleId><ArticleId IdType="pubmed">18096801</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokolov P.A., Rolich V.I., Vezo O.S., Belousov M.V., Bondarev S.A., Zhouravleva G.A., Kasyanenko N.A. Amyloid fibril length distribution from dynamic light scattering data. Eur. Biophys. J. 2022;51:325&#x2013;333. doi: 10.1007/s00249-022-01600-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00249-022-01600-5</ArticleId><ArticleId IdType="pubmed">35546203</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S., Modi P., Sharma G., Deep S. Kinetics theories to understand the mechanism of aggregation of a protein and to design strategies for its inhibition. Biophys. Chem. 2021;278:106665. doi: 10.1016/j.bpc.2021.106665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpc.2021.106665</ArticleId><ArticleId IdType="pubmed">34419715</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar E.K., Haque N., Prabhu N.P. Kinetics of protein fibril formation: Methods and mechanisms. Int. J. Biol. Macromol. 2017;100:3&#x2013;10. doi: 10.1016/j.ijbiomac.2016.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2016.06.052</ArticleId><ArticleId IdType="pubmed">27327908</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath I., Welte H., Schmit J.D., Kovermann M., Wittung-Stafshede P. Distinct growth regimes of alpha-synuclein amyloid elongation. Biophys. J. 2023;122:2556&#x2013;2563. doi: 10.1016/j.bpj.2023.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2023.05.009</ArticleId><ArticleId IdType="pmc">PMC10323017</ArticleId><ArticleId IdType="pubmed">37170496</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowles T.P.J., Waudby C.A., Devlin G.L., Cohen S.I., Aguzzi A., Vendruscolo M., Terentjev E.M., Welland M.E., Dobson C.M. An analytical solution to the kinetics of breakable filament assembly. Science. 2009;326:1533&#x2013;1537. doi: 10.1126/science.1178250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1178250</ArticleId><ArticleId IdType="pubmed">20007899</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G.F., Xu T.H., Yan Y., Zhou Y.R., Jiang Y., Melcher K., Xu H.E. Amyloid beta: Structure, biology and structure-based therapeutic development. Acta Pharmacol. Sin. 2017;38:1205&#x2013;1235. doi: 10.1038/aps.2017.28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2017.28</ArticleId><ArticleId IdType="pmc">PMC5589967</ArticleId><ArticleId IdType="pubmed">28713158</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Cao C., Loch R.A., Tiiman A., Luo J. Single-molecule studies of amyloid proteins: From biophysical properties to diagnostic perspectives. Q. Rev. Biophys. 2020;53:e12. doi: 10.1017/S0033583520000086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033583520000086</ArticleId><ArticleId IdType="pubmed">33148356</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaels T.C.T., Saric A., Habchi J., Chia S., Meisl G., Vendruscolo M., Dobson C.M., Knowles T.P.J. Chemical Kinetics for Bridging Molecular Mechanisms and Macroscopic Measurements of Amyloid Fibril Formation. Annu. Rev. Phys. Chem. 2018;69:273&#x2013;298. doi: 10.1146/annurev-physchem-050317-021322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physchem-050317-021322</ArticleId><ArticleId IdType="pubmed">29490200</ArticleId></ArticleIdList></Reference><Reference><Citation>Meisl G., Michaels T.C.T., Linse S., Knowles T.P.J. Kinetic Analysis of Amyloid Formation. Methods Mol. Biol. 2018;1779:181&#x2013;196. doi: 10.1007/978-1-4939-7816-8_12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-7816-8_12</ArticleId><ArticleId IdType="pubmed">29886534</ArticleId></ArticleIdList></Reference><Reference><Citation>Dear A.J., Michaels T.C.T., Meisl G., Klenerman D., Wu S., Perrett S., Linse S., Dobson C.M., Knowles T.P.J. Kinetic diversity of amyloid oligomers. Proc. Natl. Acad. Sci. USA. 2020;117:12087&#x2013;12094. doi: 10.1073/pnas.1922267117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1922267117</ArticleId><ArticleId IdType="pmc">PMC7275774</ArticleId><ArticleId IdType="pubmed">32414930</ArticleId></ArticleIdList></Reference><Reference><Citation>Arosio P., Knowles T.P.J., Linse S. On the lag phase in amyloid fibril formation. Phys. Chem. Chem. Phys. 2015;17:7606&#x2013;7618. doi: 10.1039/C4CP05563B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C4CP05563B</ArticleId><ArticleId IdType="pmc">PMC4498454</ArticleId><ArticleId IdType="pubmed">25719972</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., Taddei N., Ramponi G., Dobson C.M., Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 2002;416:507&#x2013;511. doi: 10.1038/416507a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/416507a</ArticleId><ArticleId IdType="pubmed">11932737</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucciantini M., Calloni G., Chiti F., Formigli L., Nosi D., Dobson C.M., Stefani M. Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J. Biol. Chem. 2004;279:31374&#x2013;31382. doi: 10.1074/jbc.M400348200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M400348200</ArticleId><ArticleId IdType="pubmed">15133040</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaels T.C.T., Saric A., Meisl G., Heller G.T., Curk S., Arosio P., Linse S., Dobson C.M., Vendruscolo M., Knowles T.P.J. Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors. Proc. Natl. Acad. Sci. USA. 2020;117:24251&#x2013;24257. doi: 10.1073/pnas.2006684117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2006684117</ArticleId><ArticleId IdType="pmc">PMC7533883</ArticleId><ArticleId IdType="pubmed">32929030</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulatskaya A.I., Rodina N.P., Sulatsky M.I., Povarova O.I., Antifeeva I.A., Kuznetsova I.M., Turoverov K.K. Investigation of alpha-Synuclein Amyloid Fibrils Using the Fluorescent Probe Thioflavin T. Int. J. Mol. Sci. 2018;19:2486. doi: 10.3390/ijms19092486.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19092486</ArticleId><ArticleId IdType="pmc">PMC6163839</ArticleId><ArticleId IdType="pubmed">30142878</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirt S.J. Principles of microbe and cell cultivation. Wiley; London, UK: 1975.</Citation></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/ Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Q., Liao L., Cheng D., Duong D.M., Gearing M., Lah J.J., Levey A.I., Peng J. Proteomic identification of novel proteins associated with Lewy bodies. Front. Biosci. 2008;13:3850&#x2013;3856. doi: 10.2741/2973.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/2973</ArticleId><ArticleId IdType="pmc">PMC2663966</ArticleId><ArticleId IdType="pubmed">18508479</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsamourgelis A., Swann P., Chouliaras L., O&#x2019;Brien J.T. From protein biomarkers to proteomics in dementia with Lewy Bodies. Ageing Res. Rev. 2023;83:101771. doi: 10.1016/j.arr.2022.101771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2022.101771</ArticleId><ArticleId IdType="pubmed">36328346</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath I., Wittung-Stafshede P. Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson&#x2019;s disease. Proc. Natl. Acad. Sci. USA. 2016;113:12473&#x2013;12477. doi: 10.1073/pnas.1610371113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1610371113</ArticleId><ArticleId IdType="pmc">PMC5098634</ArticleId><ArticleId IdType="pubmed">27791129</ArticleId></ArticleIdList></Reference><Reference><Citation>Werner T., Horvath I., Wittung-Stafshede P. Crosstalk between Alpha-Synuclein and Other Human and Non-Human Amyloidogenic Proteins: Consequences for Amyloid Formation in Parkinson&#x2019;s Disease. J. Park. Dis. 2020;10:819&#x2013;830. doi: 10.3233/JPD-202085.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-202085</ArticleId><ArticleId IdType="pmc">PMC7458506</ArticleId><ArticleId IdType="pubmed">32538869</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittung-Stafshede P. Gut power: Modulation of human amyloid formation by amyloidogenic proteins in the gastrointestinal tract. Curr. Opin. Struct. Biol. 2022;72:33&#x2013;38. doi: 10.1016/j.sbi.2021.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2021.07.009</ArticleId><ArticleId IdType="pubmed">34450484</ArticleId></ArticleIdList></Reference><Reference><Citation>Slamova I., Adib R., Ellmerich S., Golos M.R., Gilbertson J.A., Botcher N., Canetti D., Taylor G.W., Rendell N., Tennent G.A., et al. Plasmin activity promotes amyloid deposition in a transgenic model of human transthyretin amyloidosis. Nat. Commun. 2021;12:7112. doi: 10.1038/s41467-021-27416-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27416-z</ArticleId><ArticleId IdType="pmc">PMC8651690</ArticleId><ArticleId IdType="pubmed">34876572</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhasne K., Mukhopadhyay S. Formation of Heterotypic Amyloids: Alpha-Synuclein in Co-Aggregation. Proteomics. 2018;18:e1800059. doi: 10.1002/pmic.201800059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201800059</ArticleId><ArticleId IdType="pubmed">30216674</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhasne K., Sebastian S., Jain N., Mukhopadhyay S. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered alpha-Synuclein and Tau. J. Mol. Biol. 2018;430:2508&#x2013;2520. doi: 10.1016/j.jmb.2018.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2018.04.020</ArticleId><ArticleId IdType="pubmed">29704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu R., Zhang M., Chen H., Jiang B., Zheng J. Cross-Seeding Interaction between beta-Amyloid and Human Islet Amyloid Polypeptide. ACS Chem. Neurosci. 2015;6:1759&#x2013;1768. doi: 10.1021/acschemneuro.5b00192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.5b00192</ArticleId><ArticleId IdType="pubmed">26255739</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanova M.I., Lin Y., Lee Y.H., Zheng J., Ramamoorthy A. Biophysical processes underlying cross-seeding in amyloid aggregation and implications in amyloid pathology. Biophys. Chem. 2021;269:106507. doi: 10.1016/j.bpc.2020.106507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpc.2020.106507</ArticleId><ArticleId IdType="pmc">PMC10317075</ArticleId><ArticleId IdType="pubmed">33254009</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundmark K., Westermark G.T., Olsen A., Westermark P. Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: Cross-seeding as a disease mechanism. Proc. Natl. Acad. Sci. USA. 2005;102:6098&#x2013;6102. doi: 10.1073/pnas.0501814102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0501814102</ArticleId><ArticleId IdType="pmc">PMC1087940</ArticleId><ArticleId IdType="pubmed">15829582</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales R., Moreno-Gonzalez I., Soto C. Cross-Seeding of Misfolded Proteins: Implications for Etiology and Pathogenesis of Protein Misfolding Diseases. PLoS Pathog. 2013;9:e1003537. doi: 10.1371/journal.ppat.1003537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003537</ArticleId><ArticleId IdType="pmc">PMC3777858</ArticleId><ArticleId IdType="pubmed">24068917</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono K., Takahashi R., Ikeda T., Yamada M. Cross-seeding effects of amyloid beta-protein and alpha-synuclein. J. Neurochem. 2012;122:883&#x2013;890. doi: 10.1111/j.1471-4159.2012.07847.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2012.07847.x</ArticleId><ArticleId IdType="pubmed">22734715</ArticleId></ArticleIdList></Reference><Reference><Citation>Oskarsson M.E., Paulsson J.F., Schultz S.W., Ingelsson M., Westermark P., Westermark G.T. In vivo seeding and cross-seeding of localized amyloidosis: A molecular link between type 2 diabetes and Alzheimer disease. Am. J. Pathol. 2015;185:834&#x2013;846. doi: 10.1016/j.ajpath.2014.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2014.11.016</ArticleId><ArticleId IdType="pubmed">25700985</ArticleId></ArticleIdList></Reference><Reference><Citation>Subedi S., Sasidharan S., Nag N., Saudagar P., Tripathi T. Amyloid Cross-Seeding: Mechanism, Implication, and Inhibition. Molecules. 2022;27:1776. doi: 10.3390/molecules27061776.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27061776</ArticleId><ArticleId IdType="pmc">PMC8955620</ArticleId><ArticleId IdType="pubmed">35335141</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Hu R., Chen H., Chang Y., Ma J., Liang G., Mi J., Wang Y., Zheng J. Polymorphic cross-seeding amyloid assemblies of amyloid-beta and human islet amyloid polypeptide. Phys. Chem. Chem. Phys. 2015;17:23245&#x2013;23256. doi: 10.1039/C5CP03329B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5CP03329B</ArticleId><ArticleId IdType="pubmed">26283068</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge W.Y., Deng X., Shi W.P., Lin W.J., Chen L.L., Liang H., Wang X.T., Zhang T.D., Zhao F.Z., Guo W.H., et al. Amyloid Protein Cross-Seeding Provides a New Perspective on Multiple Diseases In Vivo. Biomacromolecules. 2023;24:1&#x2013;18. doi: 10.1021/acs.biomac.2c01233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biomac.2c01233</ArticleId><ArticleId IdType="pubmed">36507729</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Zhang M., Liu Y., Zhang D., Tang Y., Ren B., Zheng J. Dual amyloid cross-seeding reveals steric zipper-facilitated fibrillization and pathological links between protein misfolding diseases. J. Mater. Chem. B. 2021;9:3300&#x2013;3316. doi: 10.1039/D0TB02958K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D0TB02958K</ArticleId><ArticleId IdType="pubmed">33651875</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren B., Zhang Y., Zhang M., Liu Y., Zhang D., Gong X., Feng Z., Tang J., Chang Y., Zheng J. Fundamentals of cross-seeding of amyloid proteins: An introduction. J. Mater. Chem. B. 2019;7:7267&#x2013;7282. doi: 10.1039/C9TB01871A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C9TB01871A</ArticleId><ArticleId IdType="pubmed">31647489</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren B., Hu R., Zhang M., Liu Y., Xu L., Jiang B., Ma J., Ma B., Nussinov R., Zheng J. Experimental and Computational Protocols for Studies of Cross-Seeding Amyloid Assemblies. Methods Mol. Biol. 2018;1777:429&#x2013;447. doi: 10.1007/978-1-4939-7811-3_27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-7811-3_27</ArticleId><ArticleId IdType="pmc">PMC6456059</ArticleId><ArticleId IdType="pubmed">29744852</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong J.Y., Wang J.Y., Yue H.W., Zhang X.L., Zhang S.X., Jiang L.L., Hu H.Y. Coaggregation of polyglutamine (polyQ) proteins is mediated by polyQ-tract interactions and impairs cellular proteostasis. Acta Biochim. Biophys. Sin. 2023;55:736&#x2013;748. doi: 10.3724/abbs.2023081.</Citation><ArticleIdList><ArticleId IdType="doi">10.3724/abbs.2023081</ArticleId><ArticleId IdType="pmc">PMC10281877</ArticleId><ArticleId IdType="pubmed">37171184</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhuri P., Prajapati K.P., Anand B.G., Dubey K., Kar K. Amyloid cross-seeding raises new dimensions to understanding of amyloidogenesis mechanism. Ageing Res. Rev. 2019;56:100937. doi: 10.1016/j.arr.2019.100937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2019.100937</ArticleId><ArticleId IdType="pubmed">31430565</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami K., Ono K. Interactions of amyloid coaggregates with biomolecules and its relevance to neurodegeneration. FASEB J. 2022;36:e22493. doi: 10.1096/fj.202200235R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202200235R</ArticleId><ArticleId IdType="pubmed">35971743</ArticleId></ArticleIdList></Reference><Reference><Citation>Westermark G.T., Fandrich M., Lundmark K., Westermark P. Noncerebral Amyloidoses: Aspects on Seeding, Cross-Seeding, and Transmission. Cold Spring Harb. Perspect. Med. 2018;8:a024323. doi: 10.1101/cshperspect.a024323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024323</ArticleId><ArticleId IdType="pmc">PMC5749146</ArticleId><ArticleId IdType="pubmed">28108533</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto N., Matsuzaki K., Yanagisawa K. Cross-seeding of wild-type and hereditary variant-type amyloid beta-proteins in the presence of gangliosides. J. Neurochem. 2005;95:1167&#x2013;1176. doi: 10.1111/j.1471-4159.2005.03444.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2005.03444.x</ArticleId><ArticleId IdType="pubmed">16271050</ArticleId></ArticleIdList></Reference><Reference><Citation>Peim A., Hortschansky P., Christopeit T., Schroeckh V., Richter W., Fandrich M. Mutagenic exploration of the cross-seeding and fibrillation propensity of Alzheimer&#x2019;s beta-amyloid peptide variants. Protein Sci. 2006;15:1801&#x2013;1805. doi: 10.1110/ps.062116206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1110/ps.062116206</ArticleId><ArticleId IdType="pmc">PMC2242566</ArticleId><ArticleId IdType="pubmed">16751608</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson A., Malmstr&#xf6;m S., Westermark P. Signs of cross-seeding: Aortic medin amyloid as a trigger for protein AA deposition. Amyloid. 2011;18:229&#x2013;234. doi: 10.3109/13506129.2011.630761.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13506129.2011.630761</ArticleId><ArticleId IdType="pubmed">22070546</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Smith D., Leong B.J., Brannstrom K., Almqvist F., Chapman M.R. Promiscuous cross-seeding between bacterial amyloids promotes interspecies biofilms. J. Biol. Chem. 2012;287:35092&#x2013;35103. doi: 10.1074/jbc.M112.383737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.383737</ArticleId><ArticleId IdType="pmc">PMC3471717</ArticleId><ArticleId IdType="pubmed">22891247</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartman K., Brender J.R., Monde K., Ono A., Evans M.L., Popovych N., Chapman M.R., Ramamoorthy A. Bacterial curli protein promotes the conversion of PAP248-286 into the amyloid SEVI: Cross-seeding of dissimilar amyloid sequences. PeerJ. 2013;1:e5. doi: 10.7717/peerj.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.5</ArticleId><ArticleId IdType="pmc">PMC3629062</ArticleId><ArticleId IdType="pubmed">23638387</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Hu R., Liang G., Chang Y., Sun Y., Peng Z., Zheng J. Structural and energetic insight into the cross-seeding amyloid assemblies of human IAPP and rat IAPP. J. Phys. Chem. B. 2014;118:7026&#x2013;7036. doi: 10.1021/jp5022246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jp5022246</ArticleId><ArticleId IdType="pubmed">24892388</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Hu R., Chen H., Gong X., Zhou F., Zhang L., Zheng J. Polymorphic Associations and Structures of the Cross-Seeding of Abeta1-42 and hIAPP1-37 Polypeptides. J. Chem. Inf. Model. 2015;55:1628&#x2013;1639. doi: 10.1021/acs.jcim.5b00166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.5b00166</ArticleId><ArticleId IdType="pubmed">26173078</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexandrov A.I., Serpionov G.V., Kushnirov V.V., Ter-Avanesyan M.D. Wild type huntingtin toxicity in yeast: Implications for the role of amyloid cross-seeding in polyQ diseases. Prion. 2016;10:221&#x2013;227. doi: 10.1080/19336896.2016.1176659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2016.1176659</ArticleId><ArticleId IdType="pmc">PMC4981198</ArticleId><ArticleId IdType="pubmed">27220690</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu R., Ren B., Zhang M., Chen H., Liu Y., Liu L., Gong X., Jiang B., Ma J., Zheng J. Seed-Induced Heterogeneous Cross-Seeding Self-Assembly of Human and Rat Islet Polypeptides. ACS Omega. 2017;2:784&#x2013;792. doi: 10.1021/acsomega.6b00559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.6b00559</ArticleId><ArticleId IdType="pmc">PMC6044775</ArticleId><ArticleId IdType="pubmed">30023616</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Hu R., Ren B., Chen H., Jiang B., Ma J., Zheng J. Molecular Understanding of Abeta-hIAPP Cross-Seeding Assemblies on Lipid Membranes. ACS Chem. Neurosci. 2017;8:524&#x2013;537. doi: 10.1021/acschemneuro.6b00247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.6b00247</ArticleId><ArticleId IdType="pubmed">27936589</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand B.G., Prajapati K.P., Kar K. Abeta(1-40) mediated aggregation of proteins and metabolites unveils the relevance of amyloid cross-seeding in amyloidogenesis. Biochem. Biophys. Res. Commun. 2018;501:158&#x2013;164. doi: 10.1016/j.bbrc.2018.04.198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2018.04.198</ArticleId><ArticleId IdType="pubmed">29723530</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto M., Ho G., Takamatsu Y., Wada R., Sugama S., Takenouchi T., Waragai M., Masliah E. Possible Role of Amyloid Cross-Seeding in Evolvability and Neurodegenerative Disease. J. Park. Dis. 2019;9:793&#x2013;802. doi: 10.3233/JPD-191675.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-191675</ArticleId><ArticleId IdType="pmc">PMC6839461</ArticleId><ArticleId IdType="pubmed">31524179</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardin T., Daskalov A., Barrouilhet S., Granger-Farbos A., Salin B., Blancard C., Kauffmann B., Saupe S.J., Coustou V. Partial Prion Cross-Seeding between Fungal and Mammalian Amyloid Signaling Motifs. mBio. 2021;12 doi: 10.1128/mBio.02782-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02782-20</ArticleId><ArticleId IdType="pmc">PMC7885112</ArticleId><ArticleId IdType="pubmed">33563842</ArticleId></ArticleIdList></Reference><Reference><Citation>Daskalov A., Martinez D., Coustou V., El Mammeri N., Berbon M., Andreas L.B., Bardiaux B., Stanek J., Noubhani A., Kauffmann B., et al. Structural and molecular basis of cross-seeding barriers in amyloids. Proc. Natl. Acad. Sci. USA. 2021;118:e2014085118. doi: 10.1073/pnas.2014085118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2014085118</ArticleId><ArticleId IdType="pmc">PMC7817211</ArticleId><ArticleId IdType="pubmed">33443172</ArticleId></ArticleIdList></Reference><Reference><Citation>Koloteva-Levine N., Aubrey L.D., Marchante R., Purton T.J., Hiscock J.R., Tuite M.F., Xue W.F. Amyloid particles facilitate surface-catalyzed cross-seeding by acting as promiscuous nanoparticles. Proc. Natl. Acad. Sci. USA. 2021;118:e2104148118. doi: 10.1073/pnas.2104148118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2104148118</ArticleId><ArticleId IdType="pmc">PMC8433567</ArticleId><ArticleId IdType="pubmed">34462352</ArticleId></ArticleIdList></Reference><Reference><Citation>Nirwal S., Bharathi V., Patel B.K. Amyloid-like aggregation of bovine serum albumin at physiological temperature induced by cross-seeding effect of HEWL amyloid aggregates. Biophys. Chem. 2021;278:106678. doi: 10.1016/j.bpc.2021.106678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpc.2021.106678</ArticleId><ArticleId IdType="pubmed">34492451</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaneyck J., Segers-Nolten I., Broersen K., Claessens M.M.A.E. Cross-seeding of alpha-synuclein aggregation by amyloid fibrils of food proteins. J. Biol. Chem. 2021;296:100358. doi: 10.1016/j.jbc.2021.100358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100358</ArticleId><ArticleId IdType="pmc">PMC7949133</ArticleId><ArticleId IdType="pubmed">33539920</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuzu K., Yamamoto N., Noji M., So M., Goto Y., Iwasaki T., Tsubaki M., Chatani E. Multistep Changes in Amyloid Structure Induced by Cross-Seeding on a Rugged Energy Landscape. Biophys. J. 2021;120:284&#x2013;295. doi: 10.1016/j.bpj.2020.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2020.12.005</ArticleId><ArticleId IdType="pmc">PMC7840402</ArticleId><ArticleId IdType="pubmed">33340544</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y., Zhang D., Liu Y., Zhang Y., Zhou Y., Chang Y., Zheng B., Xu A., Zheng J. A new strategy to reconcile amyloid cross-seeding and amyloid prevention in a binary system of alpha-synuclein fragmental peptide and hIAPP. Protein Sci. 2022;31:485&#x2013;497. doi: 10.1002/pro.4247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.4247</ArticleId><ArticleId IdType="pmc">PMC8820123</ArticleId><ArticleId IdType="pubmed">34850985</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y., Zhang D., Chang Y., Zheng J. Atrial Natriuretic Peptide Associated with Cardiovascular Diseases Inhibits Amyloid-beta Aggregation via Cross-Seeding. ACS Chem. Neurosci. 2023;14:312&#x2013;322. doi: 10.1021/acschemneuro.2c00712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.2c00712</ArticleId><ArticleId IdType="pubmed">36577130</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y., Zhang D., Zheng J. Repurposing Antimicrobial Protegrin-1 as a Dual-Function Amyloid Inhibitor via Cross-seeding. ACS Chem. Neurosci. 2023;14:3143&#x2013;3155. doi: 10.1021/acschemneuro.3c00293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.3c00293</ArticleId><ArticleId IdType="pubmed">37589476</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan X., Zhang X., Yan J., Xu H., Zhao W., Ding F., Huang F., Sun Y. Computational Investigation of Coaggregation and Cross-Seeding between Abeta and hIAPP Underpinning the Cross-Talk in Alzheimer&#x2019;s Disease and Type 2 Diabetes. J. Chem. Inf. Model. 2024;64:5303&#x2013;5316. doi: 10.1021/acs.jcim.4c00859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jcim.4c00859</ArticleId><ArticleId IdType="pmc">PMC11339732</ArticleId><ArticleId IdType="pubmed">38921060</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Bergstrom J., Ingelsson M., Westermark G.T. Studies on alpha-synuclein and islet amyloid polypeptide interaction. Front. Mol. Biosci. 2023;10:1080112. doi: 10.3389/fmolb.2023.1080112.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2023.1080112</ArticleId><ArticleId IdType="pmc">PMC9922763</ArticleId><ArticleId IdType="pubmed">36793785</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Westermark G.T. The Amyloid Forming Peptides Islet Amyloid Polypeptide and Amyloid beta Interact at the Molecular Level. Int. J. Mol. Sci. 2021;22:11153. doi: 10.3390/ijms222011153.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222011153</ArticleId><ArticleId IdType="pmc">PMC8541034</ArticleId><ArticleId IdType="pubmed">34681811</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Berthelier V., Yang W., Wetzel R. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. J. Mol. Biol. 2001;311:173&#x2013;182. doi: 10.1006/jmbi.2001.4850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.2001.4850</ArticleId><ArticleId IdType="pubmed">11469866</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Berthelier V., Hamilton J.B., O&#x2019;Nuallain B., Wetzel R. Amyloid-like features of polyglutamine aggregates and their assembly kinetics. Biochemistry. 2002;41:7391&#x2013;7399. doi: 10.1021/bi011772q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi011772q</ArticleId><ArticleId IdType="pubmed">12044172</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider R., Schumacher M.C., Mueller H., Nand D., Klaukien V., Heise H., Riedel D., Wolf G., Behrmann E., Raunser S., et al. Structural characterization of polyglutamine fibrils by solid-state NMR spectroscopy. J. Mol. Biol. 2011;412:121&#x2013;136. doi: 10.1016/j.jmb.2011.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2011.06.045</ArticleId><ArticleId IdType="pubmed">21763317</ArticleId></ArticleIdList></Reference><Reference><Citation>Punihaole D., Workman R.J., Hong Z., Madura J.D., Asher S.A. Polyglutamine Fibrils: New Insights into Antiparallel beta-Sheet Conformational Preference and Side Chain Structure. J. Phys. Chem. B. 2016;120:3012&#x2013;3026. doi: 10.1021/acs.jpcb.5b11380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpcb.5b11380</ArticleId><ArticleId IdType="pubmed">26947327</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang R.K., Baxa U., Aldrian G., Ahmed A.B., Wall J.S., Mizuno N., Antzutkin O., Steven A.C., Kajava A.V. Conformational switching in PolyGln amyloid fibrils resulting from a single amino acid insertion. Biophys. J. 2014;106:2134&#x2013;2142. doi: 10.1016/j.bpj.2014.03.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2014.03.047</ArticleId><ArticleId IdType="pmc">PMC4052364</ArticleId><ArticleId IdType="pubmed">24853742</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B. Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson&#x2019;s, Huntington&#x2019;s, Alzheimer&#x2019;s, prions, bactericides, chemical toxicology and others as examples. Arch. Toxicol. 2010;577:825&#x2013;889.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2988997</ArticleId><ArticleId IdType="pubmed">20967426</ArticleId></ArticleIdList></Reference><Reference><Citation>Bondarev S.A., Antonets K.S., Kajava A.V., Nizhnikov A.A., Zhouravleva G.A. Protein Co-Aggregation Related to Amyloids: Methods of Investigation, Diversity, and Classification. Int. J. Mol. Sci. 2018;19:2292. doi: 10.3390/ijms19082292.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19082292</ArticleId><ArticleId IdType="pmc">PMC6121665</ArticleId><ArticleId IdType="pubmed">30081572</ArticleId></ArticleIdList></Reference><Reference><Citation>Kajava A.V., Baxa U., Steven A.C. Beta arcades: Recurring motifs in naturally occurring and disease-related amyloid fibrils. FASEB J. 2010;24:1311&#x2013;1319. doi: 10.1096/fj.09-145979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.09-145979</ArticleId><ArticleId IdType="pmc">PMC2879952</ArticleId><ArticleId IdType="pubmed">20032312</ArticleId></ArticleIdList></Reference><Reference><Citation>Luckgei N., Schutz A.K., Bousset L., Habenstein B., Sourigues Y., Gardiennet C., Meier B.H., Melki R., Bockmann A. The conformation of the prion domain of Sup35p in isolation and in the full-length protein. Angew. Chem. Int. Ed. Engl. 2013;52:12741&#x2013;12744. doi: 10.1002/anie.201304699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201304699</ArticleId><ArticleId IdType="pubmed">24123863</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xfc;hrs T., Ritter C., Adrian M., Riek-Loher D., Bohrmann B., Dobeli H., Schubert D., Riek R. 3D structure of Alzheimer&#x2019;s amyloid-beta(1-42) fibrils. Proc. Natl. Acad. Sci. USA. 2005;102:17342&#x2013;17347. doi: 10.1073/pnas.0506723102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0506723102</ArticleId><ArticleId IdType="pmc">PMC1297669</ArticleId><ArticleId IdType="pubmed">16293696</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez de Groot N., Torrent M., Villar-Piqu&#xe9; A., Lang B., Ventura S., Gsponer J., Babu M.M. Evolutionary selection for protein aggregation. Biochem. Soc. Trans. 2012;40:1032&#x2013;1037. doi: 10.1042/BST20120160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20120160</ArticleId><ArticleId IdType="pubmed">22988860</ArticleId></ArticleIdList></Reference><Reference><Citation>Weirich F., Gremer L., Mirecka E.A., Schiefer S., Hoyer W., Heise H. Structural Characterization of Fibrils from Recombinant Human Islet Amyloid Polypeptide by Solid-State NMR: The Central FGAILS Segment Is Part of the beta-Sheet Core. PLoS ONE. 2016;11:e0161243. doi: 10.1371/journal.pone.0161243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0161243</ArticleId><ArticleId IdType="pmc">PMC5015977</ArticleId><ArticleId IdType="pubmed">27607147</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., McQuade T., Siemer A.B., Napetschnig J., Moriwaki K., Hsiao Y.S., Damko E., Moquin D., Walz T., McDermott A., et al. The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis. Cell. 2012;150:339&#x2013;350. doi: 10.1016/j.cell.2012.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.06.019</ArticleId><ArticleId IdType="pmc">PMC3664196</ArticleId><ArticleId IdType="pubmed">22817896</ArticleId></ArticleIdList></Reference><Reference><Citation>Kajava A.V., Klopffleisch K., Chen S., Hofmann K. Evolutionary link between metazoan RHIM motif and prion-forming domain of fungal heterokaryon incompatibility factor HET-s/HET-s. Sci. Rep. 2014;4:7436. doi: 10.1038/srep07436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep07436</ArticleId><ArticleId IdType="pmc">PMC4262963</ArticleId><ArticleId IdType="pubmed">25500536</ArticleId></ArticleIdList></Reference><Reference><Citation>Azizyan R.A., Wang W., Anikeenko A., Radkova Z., Bakulina A., Garro A., Charlier L., Dumas C., Ventura S., Kajava A.V. Amyloidogenicity as a driving force for the formation of functional oligomers. J. Struct. Biol. 2020;212:107604. doi: 10.1016/j.jsb.2020.107604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2020.107604</ArticleId><ArticleId IdType="pubmed">32805411</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn H.J., Zamolodchikov D., Cortes-Canteli M., Norris E.H., Glickman J.F., Strickland S. Alzheimer&#x2019;s disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization. Proc. Natl. Acad. Sci. USA. 2010;107:21812&#x2013;21817. doi: 10.1073/pnas.1010373107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1010373107</ArticleId><ArticleId IdType="pmc">PMC3003082</ArticleId><ArticleId IdType="pubmed">21098282</ArticleId></ArticleIdList></Reference><Reference><Citation>Biza K.V., Nastou K.C., Tsiolaki P.L., Mastrokalou C.V., Hamodrakas S.J., Iconomidou V.A. The amyloid interactome: Exploring protein aggregation. PLoS ONE. 2017;12:e0173163. doi: 10.1371/journal.pone.0173163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0173163</ArticleId><ArticleId IdType="pmc">PMC5383009</ArticleId><ArticleId IdType="pubmed">28249044</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. Proteomic evidence for amyloidogenic cross-seeding in fibrinaloid microclots. bioRxiv. 2024 doi: 10.1101/2024.07.16.603837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.07.16.603837</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger A., Vlok M., Turner S., Venter C., Laubscher G.J., Kell D.B., Pretorius E. Proteomics of fibrin amyloid microclots in Long COVID/ Post-Acute Sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc. Diabetol. 2022;21:190. doi: 10.1186/s12933-022-01623-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01623-4</ArticleId><ArticleId IdType="pmc">PMC9491257</ArticleId><ArticleId IdType="pubmed">36131342</ArticleId></ArticleIdList></Reference><Reference><Citation>Hortin G.L., Sviridov D., Anderson N.L. High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. Clin. Chem. 2008;54:1608&#x2013;1616. doi: 10.1373/clinchem.2008.108175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2008.108175</ArticleId><ArticleId IdType="pubmed">18687737</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson N.L., Anderson N.G. The human plasma proteome: History, character, and diagnostic prospects. Mol. Cell. Proteom. 2002;1:845&#x2013;867. doi: 10.1074/mcp.R200007-MCP200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.R200007-MCP200</ArticleId><ArticleId IdType="pubmed">12488461</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S.A., Joyce J., Tsuda T. Quantification of active and total transforming growth factor-beta levels in serum and solid organ tissues by bioassay. BMC Res. Notes. 2012;5:636. doi: 10.1186/1756-0500-5-636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-0500-5-636</ArticleId><ArticleId IdType="pmc">PMC3556312</ArticleId><ArticleId IdType="pubmed">23151377</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Yang C., Song Y., Jiang Y., Ding Z. Periostin gene polymorphisms, protein levels and risk of incident coronary artery disease. Mol. Biol. Rep. 2012;39:359&#x2013;367. doi: 10.1007/s11033-011-0746-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-011-0746-x</ArticleId><ArticleId IdType="pubmed">21573804</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan B.P., Campbell A.K., Luzio J.P., Siddle K. Immunoradiometric assay for human complement component C9 utilising monoclonal antibodies. Clin. Chim. Acta. 1983;134:85&#x2013;94. doi: 10.1016/0009-8981(83)90187-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0009-8981(83)90187-0</ArticleId><ArticleId IdType="pubmed">6652914</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeks I., Morgan B.P., Campbell A.K., Woodhead J.S. Measurement of C9 concentrations using an immunochemiluminometric assay. J. Immunol. Methods. 1985;80:33&#x2013;38. doi: 10.1016/0022-1759(85)90161-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-1759(85)90161-9</ArticleId><ArticleId IdType="pubmed">4008938</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopp A., Hebecker M., Svobodova E., Jozsi M. Factor H: A complement regulator in health and disease, and a mediator of cellular interactions. Biomolecules. 2012;2:46&#x2013;75. doi: 10.3390/biom2010046.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom2010046</ArticleId><ArticleId IdType="pmc">PMC4030870</ArticleId><ArticleId IdType="pubmed">24970127</ArticleId></ArticleIdList></Reference><Reference><Citation>Refetoff S. Thyroid Hormone Serum Transport Proteins. In: Feingold K.R., Anawalt B., Blackman M.R., Boyce A., Chrousos G., Corpas E., de Herder W.W., Dhatariya K., Dungan K., Hofland J., et al., editors. Endotext. MDText.com, Inc.; South Dartmouth, MA, USA: 2000.</Citation></Reference><Reference><Citation>Kanai M., Raz A., Goodman D.S. Retinol-binding protein: The transport protein for vitamin A in human plasma. J. Clin. Investig. 1968;47:2025&#x2013;2044. doi: 10.1172/JCI105889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI105889</ArticleId><ArticleId IdType="pmc">PMC297364</ArticleId><ArticleId IdType="pubmed">5675424</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Zhang L., Tian Y., Zhang T., Duan G., Liu Y., Yin Y., Hua D., Qi X., Mao Y. Serum Chemokine CXCL7 as a Diagnostic Biomarker for Colorectal Cancer. Front. Oncol. 2019;9:921. doi: 10.3389/fonc.2019.00921.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2019.00921</ArticleId><ArticleId IdType="pmc">PMC6794610</ArticleId><ArticleId IdType="pubmed">31649870</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser M., Heitmeier S., Ten Cate H., Spronk H.M.H. Role of Factor XIa and Plasma Kallikrein in Arterial and Venous Thrombosis. Thromb. Haemost. 2020;120:883&#x2013;993. doi: 10.1055/s-0040-1710013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1710013</ArticleId><ArticleId IdType="pubmed">32375196</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen C.T., Lood C., &#xd8;stergaard O., Iversen L.V., Voss A., Bengtsson A., Jacobsen S., Heegaard N.H.H. Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus. Lupus Sci. Med. 2014;1:e000026. doi: 10.1136/lupus-2014-000026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2014-000026</ArticleId><ArticleId IdType="pmc">PMC4246916</ArticleId><ArticleId IdType="pubmed">25452879</ArticleId></ArticleIdList></Reference><Reference><Citation>Buda V., Andor M., Cristescu C., Tomescu M.C., Muntean D.M., Baibata D.E., Bordejevic D.A., Danciu C., Dalleur O., Coricovac D., et al. Thrombospondin-1 Serum Levels In Hypertensive Patients with Endothelial Dysfunction after One Year Of Treatment with Perindopril. Drug Des. Dev. Ther. 2019;13:3515&#x2013;3526. doi: 10.2147/DDDT.S218428.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S218428</ArticleId><ArticleId IdType="pmc">PMC6791256</ArticleId><ArticleId IdType="pubmed">31631975</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalaidopoulou Nteak S., V&#xf6;llmy F., Lukassen M.V., van den Toorn H., den Boer M.A., Bondt A., van der Lans S.P.A., Haas P.J., van Zuilen A.D., Rooijakkers S.H.M., et al. Longitudinal Fluctuations in Protein Concentrations and Higher-Order Structures in the Plasma Proteome of Kidney Failure Patients Subjected to a Kidney Transplant. J. Proteome Res. 2024;23:2124&#x2013;2136. doi: 10.1021/acs.jproteome.4c00064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.4c00064</ArticleId><ArticleId IdType="pmc">PMC11165583</ArticleId><ArticleId IdType="pubmed">38701233</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.C., Han S.H., Lee H., Jeong H., Byun M.S., Bae J., Kim H., Lee D.Y., Yi D., Shin S.A., et al. Prognostic plasma protein panel for Abeta deposition in the brain in Alzheimer&#x2019;s disease. Prog. Neurobiol. 2019;183:101690. doi: 10.1016/j.pneurobio.2019.101690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2019.101690</ArticleId><ArticleId IdType="pubmed">31605717</ArticleId></ArticleIdList></Reference><Reference><Citation>Son S.M., Nam D.W., Cha M.Y., Kim K.H., Byun J., Ryu H., Mook-Jung I. Thrombospondin-1 prevents amyloid beta-mediated synaptic pathology in Alzheimer&#x2019;s disease. Neurobiol. Aging. 2015;36:3214&#x2013;3227. doi: 10.1016/j.neurobiolaging.2015.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.09.005</ArticleId><ArticleId IdType="pubmed">26452999</ArticleId></ArticleIdList></Reference><Reference><Citation>Drolle E., Hane F., Lee B., Leonenko Z. Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer&#x2019;s disease. Drug Metab. Rev. 2014;46:207&#x2013;223. doi: 10.3109/03602532.2014.882354.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/03602532.2014.882354</ArticleId><ArticleId IdType="pubmed">24495298</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin E.J., Park J.W. Nanoaggregates Derived from Amyloid-beta and Alpha-synuclein Characterized by Sequential Quadruple Force Mapping. Nano Lett. 2021;21:3789&#x2013;3797. doi: 10.1021/acs.nanolett.1c00058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.nanolett.1c00058</ArticleId><ArticleId IdType="pubmed">33845574</ArticleId></ArticleIdList></Reference><Reference><Citation>Vadukul D.M., Papp M., Thrush R.J., Wang J., Jin Y., Arosio P., Aprile F.A. alpha-Synuclein Aggregation Is Triggered by Oligomeric Amyloid-beta 42 via Heterogeneous Primary Nucleation. J. Am. Chem. Soc. 2023;145:18276&#x2013;18285. doi: 10.1021/jacs.3c03212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.3c03212</ArticleId><ArticleId IdType="pmc">PMC10450681</ArticleId><ArticleId IdType="pubmed">37556728</ArticleId></ArticleIdList></Reference><Reference><Citation>Biessels G.J., Staekenborg S., Brunner E., Brayne C., Scheltens P. Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol. 2006;5:64&#x2013;74. doi: 10.1016/S1474-4422(05)70284-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(05)70284-2</ArticleId><ArticleId IdType="pubmed">16361024</ArticleId></ArticleIdList></Reference><Reference><Citation>Swasthi H.M., Bhasne K., Mahapatra S., Mukhopadhyay S. Human Fibrinogen Inhibits Amyloid Assembly of Biofilm-Forming CsgA. Biochemistry. 2018;57:6270&#x2013;6273. doi: 10.1021/acs.biochem.8b00841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.8b00841</ArticleId><ArticleId IdType="pubmed">30338995</ArticleId></ArticleIdList></Reference><Reference><Citation>Najarzadeh Z., Nielsen J., Farzadfard A., Sereikaite V., Stromgaard K., Meyer R.L., Otzen D.E. Human Fibrinogen Inhibits Amyloid Assembly of Most Phenol-Soluble Modulins from Staphylococcus aureus. ACS Omega. 2021;6:21960&#x2013;21970. doi: 10.1021/acsomega.1c02333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.1c02333</ArticleId><ArticleId IdType="pmc">PMC8412925</ArticleId><ArticleId IdType="pubmed">34497891</ArticleId></ArticleIdList></Reference><Reference><Citation>Niemietz C., Bezerra F., Almeida M.R., Guo S., Monia B.P., Saraiva M.J., Schutz P., Schmidt H.H., Zibert A. SERPINA1 modulates expression of amyloidogenic transthyretin. Exp. Cell Res. 2020;395:112217. doi: 10.1016/j.yexcr.2020.112217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2020.112217</ArticleId><ArticleId IdType="pubmed">32768500</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezerra F., Niemietz C., Schmidt H.H.J., Zibert A., Guo S., Monia B.P., Goncalves P., Saraiva M.J., Almeida M.R. In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin Proteolysis. Int. J. Mol. Sci. 2021;22:9488. doi: 10.3390/ijms22179488.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22179488</ArticleId><ArticleId IdType="pmc">PMC8430710</ArticleId><ArticleId IdType="pubmed">34502397</ArticleId></ArticleIdList></Reference><Reference><Citation>Niemietz C., Fleischhauer L., Sandfort V., Guttmann S., Zibert A., Schmidt H.H. Hepatocyte-like cells reveal novel role of SERPINA1 in transthyretin amyloidosis. J. Cell Sci. 2018;131:jcs.219824. doi: 10.1242/jcs.219824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.219824</ArticleId><ArticleId IdType="pubmed">30333144</ArticleId></ArticleIdList></Reference><Reference><Citation>Berndsen Z.T., Cassidy C.K. The Structure of ApoB100 from Human Low-density Lipoprotein. bioRxiv. 2024 doi: 10.1101/2024.02.28.582555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.02.28.582555</ArticleId></ArticleIdList></Reference><Reference><Citation>Namba Y., Tsuchiya H., Ikeda K. Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer&#x2019;s disease. Neurosci. Lett. 1992;134:264&#x2013;266. doi: 10.1016/0304-3940(92)90531-B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(92)90531-B</ArticleId><ArticleId IdType="pubmed">1375354</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobler C., Maphumulo S.C., Grobbelaar L.M., Bredenkamp` J., Laubscher J., Lourens P.J., Steenkamp J., Kell D.B., Pretorius E. COVID-19: The Rollercoaster of Fibrin(ogen), D-dimer, von Willebrand Factor, P-selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes. Int. J. Mol. Sci. 2020;21:5168. doi: 10.3390/ijms21145168.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21145168</ArticleId><ArticleId IdType="pmc">PMC7403995</ArticleId><ArticleId IdType="pubmed">32708334</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.W., Byun M.S., Yi D., Kim M.J., Jung J.H., Kong N., Jung G., Ahn H., Lee J.Y., Kang K.M., et al. Serum Adiponectin and In Vivo Brain Amyloid Deposition in Cognitively Normal Older Adults: A Cohort Study. Aging Dis. 2023;14:904&#x2013;918. doi: 10.14336/AD.2022.1118.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2022.1118</ArticleId><ArticleId IdType="pmc">PMC10187695</ArticleId><ArticleId IdType="pubmed">37191420</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan K.H., Lam K.S., Cheng O.Y., Kwan J.S., Ho P.W., Cheng K.K., Chung S.K., Ho J.W., Guo V.Y., Xu A. Adiponectin is protective against oxidative stress induced cytotoxicity in amyloid-beta neurotoxicity. PLoS ONE. 2012;7:e52354. doi: 10.1371/journal.pone.0052354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052354</ArticleId><ArticleId IdType="pmc">PMC3531475</ArticleId><ArticleId IdType="pubmed">23300647</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S., Byun J., Son S.M., Mook-Jung I. Thrombospondin-1 protects against Abeta-induced mitochondrial fragmentation and dysfunction in hippocampal cells. Cell Death Discov. 2018;4:31. doi: 10.1038/s41420-017-0023-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-017-0023-4</ArticleId><ArticleId IdType="pmc">PMC5841271</ArticleId><ArticleId IdType="pubmed">29531828</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D.H., Lim H., Lee D., Choi S.J., Oh W., Yang Y.S., Oh J.S., Hwang H.H., Jeon H.B. Thrombospondin-1 secreted by human umbilical cord blood-derived mesenchymal stem cells rescues neurons from synaptic dysfunction in Alzheimer&#x2019;s disease model. Sci. Rep. 2018;8:354. doi: 10.1038/s41598-017-18542-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-18542-0</ArticleId><ArticleId IdType="pmc">PMC5762817</ArticleId><ArticleId IdType="pubmed">29321508</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S., Saleem S., Reed G.L. Alpha2-Antiplasmin: The Devil You Don&#x2019;t Know in Cerebrovascular and Cardiovascular Disease. Front. Cardiovasc. Med. 2020;7:608899. doi: 10.3389/fcvm.2020.608899.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2020.608899</ArticleId><ArticleId IdType="pmc">PMC7785519</ArticleId><ArticleId IdType="pubmed">33426005</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber R., Carrell R.W. Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. Biochemistry. 1989;28:8951&#x2013;8966. doi: 10.1021/bi00449a001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00449a001</ArticleId><ArticleId IdType="pubmed">2690952</ArticleId></ArticleIdList></Reference><Reference><Citation>Gettins P.G.W. Serpin structure, mechanism, and function. Chem. Rev. 2002;102:4751&#x2013;4804. doi: 10.1021/cr010170+.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cr010170+</ArticleId><ArticleId IdType="pubmed">12475206</ArticleId></ArticleIdList></Reference><Reference><Citation>Huntington J.A. Serpin structure, function and dysfunction. J. Thromb. Haemost. 2011;9((Suppl. S1)):26&#x2013;34. doi: 10.1111/j.1538-7836.2011.04360.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2011.04360.x</ArticleId><ArticleId IdType="pubmed">21781239</ArticleId></ArticleIdList></Reference><Reference><Citation>de Serres F., Blanco I. Role of alpha-1 antitrypsin in human health and disease. J. Intern. Med. 2014;276:311&#x2013;335. doi: 10.1111/joim.12239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12239</ArticleId><ArticleId IdType="pubmed">24661570</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., Zheng Y., Zhang F., Wei Z., Wang Y., Carrell R.W., Read R.J., Chen G.Q., Zhou A. Molecular Mechanism of Z alpha1-Antitrypsin Deficiency. J. Biol. Chem. 2016;291:15674&#x2013;15686. doi: 10.1074/jbc.M116.727826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.727826</ArticleId><ArticleId IdType="pmc">PMC4957051</ArticleId><ArticleId IdType="pubmed">27246852</ArticleId></ArticleIdList></Reference><Reference><Citation>Dob&#xf3; J., Gettins P.G.W. alpha1-Proteinase inhibitor forms initial non-covalent and final covalent complexes with elastase analogously to other serpin-proteinase pairs, suggesting a common mechanism of inhibition. J. Biol. Chem. 2004;279:9264&#x2013;9269. doi: 10.1074/jbc.M311731200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M311731200</ArticleId><ArticleId IdType="pubmed">14593107</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin G.L., Bottomley S.P. A protein family under &#x2018;stress&#x2019;&#x2014;Serpin stability, folding and misfolding. Front. Biosci. 2005;10:288&#x2013;299. doi: 10.2741/1528.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/1528</ArticleId><ArticleId IdType="pubmed">15574369</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolmer K., Gettins P.G.W. How the serpin alpha1-proteinase inhibitor folds. J. Biol. Chem. 2012;287:12425&#x2013;12432. doi: 10.1074/jbc.M111.315465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.315465</ArticleId><ArticleId IdType="pmc">PMC3320992</ArticleId><ArticleId IdType="pubmed">22334651</ArticleId></ArticleIdList></Reference><Reference><Citation>Pintanel-Raymundo M., Menao-Guill&#xe9;n S., Perales-Af&#xe1;n J.J., Garc&#xed;a-Guti&#xe9;rrez A., Moreno-G&#xe1;zquez I., Juli&#xe1;n-Ans&#xf3;n M., Ramos-&#xc1;lvarez M., Olivera-Gonz&#xe1;lez S., Guti&#xe9;rrez-Cia I., Torralba-Cabeza M.A. Analysis of the expression of the Serpina1 gene in SARS-CoV-2 infection: Study of a new biomarker. Rev. Cl&#xed;nica Espa&#xf1;ola. 2024;224:253&#x2013;258. doi: 10.1016/j.rce.2024.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rce.2024.03.002</ArticleId><ArticleId IdType="pubmed">38608729</ArticleId></ArticleIdList></Reference><Reference><Citation>Buhimschi I.A., Nayeri U.A., Zhao G., Shook L.L., Pensalfini A., Funai E.F., Bernstein I.M., Glabe C.G., Buhimschi C.S. Protein misfolding, congophilia, oligomerization, and defective amyloid processing in preeclampsia. Sci. Transl. Med. 2014;6:245ra292. doi: 10.1126/scitranslmed.3008808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3008808</ArticleId><ArticleId IdType="pubmed">25031267</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouza M., Banerji A., Kolinski A., Buhimschi I.A., Kloczkowski A. Oligomerization of FVFLM peptides and their ability to inhibit beta amyloid peptides aggregation: Consideration as a possible model. Phys. Chem. Chem. Phys. 2017;19:2990&#x2013;2999. doi: 10.1039/C6CP07145G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C6CP07145G</ArticleId><ArticleId IdType="pmc">PMC5305032</ArticleId><ArticleId IdType="pubmed">28079198</ArticleId></ArticleIdList></Reference><Reference><Citation>Tajiri M., Okamoto M., Fujimoto K., Johkoh T., Ono J., Tominaga M., Azuma K., Kawayama T., Ohta S., Izuhara K., et al. Serum level of periostin can predict long-term outcome of idiopathic pulmonary fibrosis. Respir. Investig. 2015;53:73&#x2013;81. doi: 10.1016/j.resinv.2014.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resinv.2014.12.003</ArticleId><ArticleId IdType="pubmed">25745852</ArticleId></ArticleIdList></Reference><Reference><Citation>Izuhara K., Nunomura S., Nanri Y., Ono J., Takai M., Kawaguchi A. Periostin: An emerging biomarker for allergic diseases. Allergy. 2019;74:2116&#x2013;2128. doi: 10.1111/all.13814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.13814</ArticleId><ArticleId IdType="pubmed">30964557</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshihara T., Morimoto T., Hirata H., Murayama M., Nonaka T., Tsukamoto M., Toda Y., Kobayashi T., Izuhara K., Mawatari M. Mechanisms of tissue degeneration mediated by periostin in spinal degenerative diseases and their implications for pathology and diagnosis: A review. Front. Med. 2023;10:1276900. doi: 10.3389/fmed.2023.1276900.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1276900</ArticleId><ArticleId IdType="pmc">PMC10645150</ArticleId><ArticleId IdType="pubmed">38020106</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki H., Roberts J., Lykins D., Fujii Y., Auclair D., Chen L.B. Novel chemiluminescence assay for serum periostin levels in women with preeclampsia and in normotensive pregnant women. Am. J. Obstet. Gynecol. 2002;186:103&#x2013;108. doi: 10.1067/mob.2002.118157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mob.2002.118157</ArticleId><ArticleId IdType="pubmed">11810094</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D., Park J.C., Jung K.S., Kim J., Jang J.S., Kwon S., Byun M.S., Yi D., Byeon G., Jung G., et al. Application of QPLEX(TM) biomarkers in cognitively normal individuals across a broad age range and diverse regions with cerebral amyloid deposition. Exp. Mol. Med. 2022;54:61&#x2013;71. doi: 10.1038/s12276-021-00719-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-021-00719-3</ArticleId><ArticleId IdType="pmc">PMC8814000</ArticleId><ArticleId IdType="pubmed">35058557</ArticleId></ArticleIdList></Reference><Reference><Citation>Naik P.K., Bozyk P.D., Bentley J.K., Popova A.P., Birch C.M., Wilke C.A., Fry C.D., White E.S., Sisson T.H., Tayob N., et al. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 2012;303:L1046&#x2013;L1056. doi: 10.1152/ajplung.00139.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00139.2012</ArticleId><ArticleId IdType="pmc">PMC3532583</ArticleId><ArticleId IdType="pubmed">23043074</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Dwyer D.N., Moore B.B. The role of periostin in lung fibrosis and airway remodeling. Cell. Mol. Life Sci. 2017;74:4305&#x2013;4314. doi: 10.1007/s00018-017-2649-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-017-2649-z</ArticleId><ArticleId IdType="pmc">PMC5659879</ArticleId><ArticleId IdType="pubmed">28918442</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W., Duan Z., Yang B., Xiao C. The Effective Regulation of Pro- and Anti-inflammatory Cytokines Induced by Combination of PA-MSHA and BPIFB1 in Initiation of Innate Immune Responses. Open Med. 2017;12:299&#x2013;307. doi: 10.1515/med-2017-0044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/med-2017-0044</ArticleId><ArticleId IdType="pmc">PMC5620450</ArticleId><ArticleId IdType="pubmed">28975158</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Xu P., Wang L., Feng M., Chen D., Yu X., Lu Y. Molecular biology of BPIFB1 and its advances in disease. Ann. Transl. Med. 2020;8:651. doi: 10.21037/atm-20-3462.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-20-3462</ArticleId><ArticleId IdType="pmc">PMC7290611</ArticleId><ArticleId IdType="pubmed">32566588</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Page M.J., Mbotwe S., Kell D.B. Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson&#x2019;s disease. PLoS ONE. 2018;13:e0192121. doi: 10.1371/journal.pone.0192121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0192121</ArticleId><ArticleId IdType="pmc">PMC5832207</ArticleId><ArticleId IdType="pubmed">29494603</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Tao Z., Jiang Y., Liu T., Xiang Y. Overexpression of BPIFB1 promotes apoptosis and inhibits proliferation via the MEK/ERK signal pathway in nasopharyngeal carcinoma. Int. J. Clin. Exp. Pathol. 2019;12:356&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6944003</ArticleId><ArticleId IdType="pubmed">31933752</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J., Xiao L., Liu J., Wang D., Zhou Y., Liao Z., Chen G. BPIFB1, Serving as a Downstream Effector of EBV-miR-BART4, Blocks Immune Escape of Nasopharyngeal Carcinoma via Inhibiting PD-L1 Expression. Biochem. Genet. 2024 doi: 10.1007/s10528-024-10719-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10528-024-10719-3</ArticleId><ArticleId IdType="pubmed">38467887</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardo T., Prattapong P., Ngernsombat C., Wisetyaningsih N., Iizasa H., Yoshiyama H., Janvilisri T. Epstein-Barr Virus Mediated Signaling in Nasopharyngeal Carcinoma Carcinogenesis. Cancers. 2020;12:2441. doi: 10.3390/cancers12092441.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12092441</ArticleId><ArticleId IdType="pmc">PMC7565514</ArticleId><ArticleId IdType="pubmed">32872147</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohmwald K., Diethelm-Varela B., Rodr&#xed;guez-Guilarte L., Rivera T., Riedel C.A., Gonz&#xe1;lez P.A., Kalergis A.M. Pathophysiological, immunological, and inflammatory features of long COVID. Front. Immunol. 2024;15:1341600. doi: 10.3389/fimmu.2024.1341600.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1341600</ArticleId><ArticleId IdType="pmc">PMC10932978</ArticleId><ArticleId IdType="pubmed">38482000</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia-Hasler C., Bruningk S.C., Hoch T., Fan B., Muzio G., Thompson R.C., Ceglarek L., Meledin R., Westermann P., Emmenegger M., et al. Persistent complement dysregulation with signs of thromboinflammation in active Long Covid. Science. 2024;383:eadg7942. doi: 10.1126/science.adg7942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.adg7942</ArticleId><ArticleId IdType="pubmed">38236961</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#x105;bczyk M., Stachowicz A., Natorska J., Olszanecki R., Wi&#x15b;niewski J.R., Undas A. Plasma fibrin clot proteomics in healthy subjects: Relation to clot permeability and lysis time. J. Proteom. 2019;208:103487. doi: 10.1016/j.jprot.2019.103487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jprot.2019.103487</ArticleId><ArticleId IdType="pubmed">31425886</ArticleId></ArticleIdList></Reference><Reference><Citation>Stathakis N.E., Fountas A., Tsianos E. Plasma fibronectin in normal subjects and in various disease states. J. Clin. Pathol. 1981;34:504&#x2013;508. doi: 10.1136/jcp.34.5.504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.34.5.504</ArticleId><ArticleId IdType="pmc">PMC493333</ArticleId><ArticleId IdType="pubmed">7251892</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosher D.F. Plasma fibronectin concentration: A risk factor for arterial thrombosis? Arterioscler. Thromb. Vasc. Biol. 2006;26:1193&#x2013;1195. doi: 10.1161/01.ATV.0000223342.15969.7a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000223342.15969.7a</ArticleId><ArticleId IdType="pubmed">16709950</ArticleId></ArticleIdList></Reference><Reference><Citation>Fucikova A., Lenco J., Tambor V., Rehulkova H., Pudil R., Stulik J. Plasma concentration of fibronectin is decreased in patients with hypertrophic cardiomyopathy. Clin. Chim. Acta. 2016;463:62&#x2013;66. doi: 10.1016/j.cca.2016.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2016.09.024</ArticleId><ArticleId IdType="pubmed">27693530</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel S., Chaffotte A.F., Goubard F., Pauthe E. Urea-induced sequential unfolding of fibronectin: A fluorescence spectroscopy and circular dichroism study. Biochemistry. 2004;43:1724&#x2013;1735. doi: 10.1021/bi0347104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi0347104</ArticleId><ArticleId IdType="pubmed">14769050</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalton C.J., Lemmon C.A. Fibronectin: Molecular Structure, Fibrillar Structure and Mechanochemical Signaling. Cells. 2021;10:2443. doi: 10.3390/cells10092443.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10092443</ArticleId><ArticleId IdType="pmc">PMC8471655</ArticleId><ArticleId IdType="pubmed">34572092</ArticleId></ArticleIdList></Reference><Reference><Citation>To W.S., Midwood K.S. Plasma and cellular fibronectin: Distinct and independent functions during tissue repair. Fibrogenesis Tissue Repair. 2011;4:21. doi: 10.1186/1755-1536-4-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-1536-4-21</ArticleId><ArticleId IdType="pmc">PMC3182887</ArticleId><ArticleId IdType="pubmed">21923916</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingham K.C., Brew S.A., Broekelmann T.J., McDonald J.A. Thermal stability of human plasma fibronectin and its constituent domains. J. Biol. Chem. 1984;259:11901&#x2013;11907. doi: 10.1016/S0021-9258(20)71297-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(20)71297-4</ArticleId><ArticleId IdType="pubmed">6434532</ArticleId></ArticleIdList></Reference><Reference><Citation>Porebski B.T., Nickson A.A., Hoke D.E., Hunter M.R., Zhu L., McGowan S., Webb G.I., Buckle A.M. Structural and dynamic properties that govern the stability of an engineered fibronectin type III domain. Protein Eng. Des. Sel. 2015;28:67&#x2013;78. doi: 10.1093/protein/gzv002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/protein/gzv002</ArticleId><ArticleId IdType="pmc">PMC4330816</ArticleId><ArticleId IdType="pubmed">25691761</ArticleId></ArticleIdList></Reference><Reference><Citation>Muszbek L., Bereczky Z., Bagoly Z., Komaromi I., Katona E. Factor XIII: A coagulation factor with multiple plasmatic and cellular functions. Physiol. Rev. 2011;91:931&#x2013;972. doi: 10.1152/physrev.00016.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00016.2010</ArticleId><ArticleId IdType="pubmed">21742792</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagoly Z., Koncz Z., H&#xe1;rsfalvi J., Muszbek L. Factor XIII, clot structure, thrombosis. Thromb. Res. 2012;129:382&#x2013;387. doi: 10.1016/j.thromres.2011.11.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2011.11.040</ArticleId><ArticleId IdType="pubmed">22197181</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole L.G., Kopec A.K., Groeneveld D.J., Pant A., Baker K.S., Cline-Fedewa H.M., Flick M.J., Luyendyk J.P. Factor XIII cross-links fibrin(ogen) independent of fibrin polymerization in experimental acute liver injury. Blood. 2021;137:2520&#x2013;2531. doi: 10.1182/blood.2020007415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007415</ArticleId><ArticleId IdType="pmc">PMC8109015</ArticleId><ArticleId IdType="pubmed">33569603</ArticleId></ArticleIdList></Reference><Reference><Citation>Standeven K.F., Carter A.M., Grant P.J., Weisel J.W., Chernysh I., Masova L., Lord S.T., Ari&#xeb;ns R.A.S. Functional analysis of fibrin {gamma}-chain cross-linking by activated factor XIII: Determination of a cross-linking pattern that maximizes clot stiffness. Blood. 2007;110:902&#x2013;907. doi: 10.1182/blood-2007-01-066837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-01-066837</ArticleId><ArticleId IdType="pubmed">17435113</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy R.M., Pallitto M.M. Probing the kinetics of beta-amyloid self-association. J. Struct. Biol. 2000;130:109&#x2013;122. doi: 10.1006/jsbi.2000.4253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jsbi.2000.4253</ArticleId><ArticleId IdType="pubmed">10940219</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly J.W. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 1998;8:101&#x2013;106. doi: 10.1016/S0959-440X(98)80016-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0959-440X(98)80016-X</ArticleId><ArticleId IdType="pubmed">9519302</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayan B., Barnea E., Khokhlov A., Upcher A., Landau M. Differential fibril morphologies and thermostability determine functional roles of Staphylococcus aureus PSMalpha1 and PSMalpha3. Front. Mol. Biosci. 2023;10:1184785. doi: 10.3389/fmolb.2023.1184785.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2023.1184785</ArticleId><ArticleId IdType="pmc">PMC10353841</ArticleId><ArticleId IdType="pubmed">37469708</ArticleId></ArticleIdList></Reference><Reference><Citation>Idicula-Thomas S., Balaji P.V. Understanding the relationship between the primary structure of proteins and their amyloidogenic propensity: Clues from inclusion body formation. Protein Eng. Des. Sel. 2005;18:175&#x2013;180. doi: 10.1093/protein/gzi022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/protein/gzi022</ArticleId><ArticleId IdType="pubmed">15849216</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimtchuk E.S., Gursky O., Patel R.S., Laporte K.L., Connors L.H., Skinner M., Seldin D.C. The critical role of the constant region in thermal stability and aggregation of amyloidogenic immunoglobulin light chain. Biochemistry. 2010;49:9848&#x2013;9857. doi: 10.1021/bi101351c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi101351c</ArticleId><ArticleId IdType="pmc">PMC4080313</ArticleId><ArticleId IdType="pubmed">20936823</ArticleId></ArticleIdList></Reference><Reference><Citation>Poshusta T.L., Katoh N., Gertz M.A., Dispenzieri A., Ramirez-Alvarado M. Thermal stability threshold for amyloid formation in light chain amyloidosis. Int. J. Mol. Sci. 2013;14:22604&#x2013;22617. doi: 10.3390/ijms141122604.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms141122604</ArticleId><ArticleId IdType="pmc">PMC3856080</ArticleId><ArticleId IdType="pubmed">24248061</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin J., Khosravi H., Bruce K.L., Lydon M.E., Behrens S.H., Chernoff Y.O., Bommarius A.S. Ion-specific effects on prion nucleation and strain formation. J. Biol. Chem. 2013;288:30300&#x2013;30308. doi: 10.1074/jbc.M113.467829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.467829</ArticleId><ArticleId IdType="pmc">PMC3798495</ArticleId><ArticleId IdType="pubmed">23990463</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes J.M., Kruger A., Proal A., Kell D.B., Pretorius E. The Occurrence of Hyperactivated Platelets and Fibrinaloid Microclots in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Pharmaceuticals. 2022;15:931. doi: 10.3390/ph15080931.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15080931</ArticleId><ArticleId IdType="pmc">PMC9413879</ArticleId><ArticleId IdType="pubmed">36015078</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes J.M., Kell D.B., Pretorius E. Cardiovascular and haematological pathology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A role for Viruses. Blood Rev. 2023;60:101075. doi: 10.1016/j.blre.2023.101075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2023.101075</ArticleId><ArticleId IdType="pmc">PMC10027292</ArticleId><ArticleId IdType="pubmed">36963989</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryabkova V.A., Gavrilova N.Y., Fedotkina T.V., Churilov L.P., Shoenfeld Y. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post-COVID Syndrome: A Common Neuroimmune Ground. Diagnostics. 2023;13:66. doi: 10.3390/diagnostics13010066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13010066</ArticleId><ArticleId IdType="pmc">PMC9818907</ArticleId><ArticleId IdType="pubmed">36611357</ArticleId></ArticleIdList></Reference><Reference><Citation>Annesley S.J., Missailidis D., Heng B., Josev E.K., Armstrong C.W. Unravelling shared mechanisms: Insights from recent ME/CFS research to illuminate long COVID pathologies. Trends Mol. Med. 2024;30:443&#x2013;458. doi: 10.1016/j.molmed.2024.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2024.02.003</ArticleId><ArticleId IdType="pubmed">38443223</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes J.M., Vlok M., Proal A., Kell D.B., Pretorius E. Data-independent LC-MS/MS analysis of ME/CFS plasma reveals a dysregulated coagulation system, endothelial dysfunction, downregulation of complement machinery. Cardiovasc. Diabetol. 2024;23:254. doi: 10.1186/s12933-024-02315-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-024-02315-x</ArticleId><ArticleId IdType="pmc">PMC11253362</ArticleId><ArticleId IdType="pubmed">39014464</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Lipkin W.I. ME/CFS and Long COVID share similar symptoms and biological abnormalities: Road map to the literature. Front. Med. 2023;10:1187163. doi: 10.3389/fmed.2023.1187163.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Lip G.Y.H., Pretorius E. Fibrinaloid Microclots and Atrial Fibrillation. Biomedicines. 2024;12:891. doi: 10.3390/biomedicines12040891.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines12040891</ArticleId><ArticleId IdType="pmc">PMC11048249</ArticleId><ArticleId IdType="pubmed">38672245</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinauro D.J., Chiti F., Vendruscolo M., Limbocker R. Misfolded protein oligomers: Mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases. Mol. Neurodegener. 2024;19:20. doi: 10.1186/s13024-023-00651-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-023-00651-2</ArticleId><ArticleId IdType="pmc">PMC10877934</ArticleId><ArticleId IdType="pubmed">38378578</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi M.K., Majid N., Malik S., Alam P., Khan R.H. Amyloid Oligomers, Protofibrils and Fibrils. Subcell. Biochem. 2019;93:471&#x2013;503. doi: 10.1007/978-3-030-28151-9_16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-28151-9_16</ArticleId><ArticleId IdType="pubmed">31939162</ArticleId></ArticleIdList></Reference><Reference><Citation>Makin O.S., Serpell L.C. Examining the structure of the mature amyloid fibril. Biochem. Soc. Trans. 2002;30:521&#x2013;525. doi: 10.1042/bst0300521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bst0300521</ArticleId><ArticleId IdType="pubmed">12196128</ArticleId></ArticleIdList></Reference><Reference><Citation>Stromer T., Serpell L.C. Structure and morphology of the Alzheimer&#x2019;s amyloid fibril. Microsc. Res. Tech. 2005;67:210&#x2013;217. doi: 10.1002/jemt.20190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jemt.20190</ArticleId><ArticleId IdType="pubmed">16103997</ArticleId></ArticleIdList></Reference><Reference><Citation>Aubrey L.D., Blakeman B.J.F., Lutter L., Serpell C.J., Tuite M.F., Serpell L.C., Xue W.F. Quantification of amyloid fibril polymorphism by nano-morphometry reveals the individuality of filament assembly. Commun. Chem. 2020;3:125. doi: 10.1038/s42004-020-00372-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42004-020-00372-3</ArticleId><ArticleId IdType="pmc">PMC9814634</ArticleId><ArticleId IdType="pubmed">36703355</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrana J.A., Theis J.D., Dasari S., Mereuta O.M., Dispenzieri A., Zeldenrust S.R., Gertz M.A., Kurtin P.J., Grogg K.L., Dogan A. Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics. Haematologica. 2014;99:1239&#x2013;1247. doi: 10.3324/haematol.2013.102764.</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2013.102764</ArticleId><ArticleId IdType="pmc">PMC4077087</ArticleId><ArticleId IdType="pubmed">24747948</ArticleId></ArticleIdList></Reference><Reference><Citation>Buxbaum J.N., Dispenzieri A., Eisenberg D.S., Fandrich M., Merlini G., Saraiva M.J.M., Sekijima Y., Westermark P. Amyloid nomenclature 2022: Update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. Amyloid. 2022;29:213&#x2013;219. doi: 10.1080/13506129.2022.2147636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13506129.2022.2147636</ArticleId><ArticleId IdType="pubmed">36420821</ArticleId></ArticleIdList></Reference><Reference><Citation>Theis J.D., Dasari S., Vrana J.A., Kurtin P.J., Dogan A. Shotgun-proteomics-based clinical testing for diagnosis and classification of amyloidosis. J. Mass. Spectrom. 2013;48:1067&#x2013;1077. doi: 10.1002/jms.3264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jms.3264</ArticleId><ArticleId IdType="pubmed">24130009</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo G., Wisniewski T., Choi-Miura N.H., Ghiso J., Frangione B. Potential role of apolipoprotein-E in fibrillogenesis. Am. J. Pathol. 1994;145:526&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1890322</ArticleId><ArticleId IdType="pubmed">8080036</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter M., Tholey A., Kr&#xfc;ger S., Schmidt H., R&#xf6;cken C. MALDI-mass spectrometry imaging identifies vitronectin as a common constituent of amyloid deposits. J. Histochem. Cytochem. 2015;63:772&#x2013;779. doi: 10.1369/0022155415595264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1369/0022155415595264</ArticleId><ArticleId IdType="pmc">PMC4823803</ArticleId><ArticleId IdType="pubmed">26101327</ArticleId></ArticleIdList></Reference><Reference><Citation>Misumi Y., Tabata Y., Tasaki M., Obayashi K., Yamakawa S., Nomura T., Ueda M. Binding of serum-derived amyloid-associated proteins to amyloid fibrils. Amyloid. 2023;30:67&#x2013;73. doi: 10.1080/13506129.2022.2120800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13506129.2022.2120800</ArticleId><ArticleId IdType="pubmed">36094798</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen) Integr. Biol. 2015;7:24&#x2013;52. doi: 10.1039/c4ib00173g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c4ib00173g</ArticleId><ArticleId IdType="pubmed">25335120</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar L.M., Venter C., Vlok M., Ngoepe M., Laubscher G.J., Lourens P.J., Steenkamp J., Kell D.B., Pretorius E. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19. Biosci. Rep. 2021;41:BSR20210611. doi: 10.1042/BSR20210611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210611</ArticleId><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu S., Mohan M.L., Luo X., Kundu B., Kong Q., Singh N. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: Implications for prion replication and disease pathogenesis. Mol. Biol. Cell. 2007;18:3302&#x2013;3312. doi: 10.1091/mbc.e07-04-0317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e07-04-0317</ArticleId><ArticleId IdType="pmc">PMC1951779</ArticleId><ArticleId IdType="pubmed">17567949</ArticleId></ArticleIdList></Reference><Reference><Citation>Candelise N., Schmitz M., Da Silva Correia S.M., Arora A.S., Villar-Pique A., Zafar S., Llorens F., Cramm M., Zerr I. Applications of the real-time quaking-induced conversion assay in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathies. Expert. Rev. Mol. Diagn. 2017;17:897&#x2013;904. doi: 10.1080/14737159.2017.1368389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737159.2017.1368389</ArticleId><ArticleId IdType="pubmed">28817974</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Wang X., Abskharon R., Ma J. Prion infectivity is encoded exclusively within the structure of proteinase K-resistant fragments of synthetically generated recombinant PrP(Sc) Acta Neuropathol. Commun. 2018;6:30. doi: 10.1186/s40478-018-0534-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0534-0</ArticleId><ArticleId IdType="pmc">PMC5921397</ArticleId><ArticleId IdType="pubmed">29699569</ArticleId></ArticleIdList></Reference><Reference><Citation>Hailemariam D., Goldansaz S.A., Daude N., Wishart D.S., Ametaj B.N. Mice Treated Subcutaneously with Mouse LPS-Converted PrP(res) or LPS Alone Showed Brain Gene Expression Profiles Characteristic of Prion Disease. Vet. Sci. 2021;8:200. doi: 10.3390/vetsci8090200.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vetsci8090200</ArticleId><ArticleId IdType="pmc">PMC8473295</ArticleId><ArticleId IdType="pubmed">34564594</ArticleId></ArticleIdList></Reference><Reference><Citation>Saverioni D., Notari S., Capellari S., Poggiolini I., Giese A., Kretzschmar H.A., Parchi P. Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions. J. Biol. Chem. 2013;288:27972&#x2013;27985. doi: 10.1074/jbc.M113.477547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.477547</ArticleId><ArticleId IdType="pmc">PMC3784711</ArticleId><ArticleId IdType="pubmed">23897825</ArticleId></ArticleIdList></Reference><Reference><Citation>Bester J., Soma P., Kell D.B., Pretorius E. Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS) Oncotarget Gerontol. 2015;6:35284&#x2013;35303. doi: 10.18632/oncotarget.6074.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.6074</ArticleId><ArticleId IdType="pmc">PMC4742105</ArticleId><ArticleId IdType="pubmed">26462180</ArticleId></ArticleIdList></Reference><Reference><Citation>de Waal G.M., Engelbrecht L., Davis T., de Villiers W.J.S., Kell D.B., Pretorius E. Correlative Light-Electron Microscopy detects lipopolysaccharide and its association with fibrin fibres in Parkinson&#x2019;s Disease, Alzheimer&#x2019;s Disease and Type 2 Diabetes Mellitus. Sci. Rep. 2018;8:16798. doi: 10.1038/s41598-018-35009-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-35009-y</ArticleId><ArticleId IdType="pmc">PMC6235901</ArticleId><ArticleId IdType="pubmed">30429533</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: The central roles of LPS and LPS-induced cell death. Integr. Biol. 2015;7:1339&#x2013;1377. doi: 10.1039/c5ib00158g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c5ib00158g</ArticleId><ArticleId IdType="pubmed">26345428</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Bester J., Page M.J., Kell D.B. The potential of LPS-binding protein to reverse amyloid formation in plasma fibrin of individuals with Alzheimer-type dementia. Front. Aging Neurosci. 2018;10:257. doi: 10.3389/fnagi.2018.00257.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00257</ArticleId><ArticleId IdType="pmc">PMC6113936</ArticleId><ArticleId IdType="pubmed">30186156</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger A., Joffe D., Lloyd-Jones G., Khan M.A., &#x160;alamon &#x160;., Laubscher G.J., Putrino D., Kell D.B., Pretorius E. Vascular pathogenesis in acute and long covid: Current insights and therapeutic outlook. Semin. Throm Hemost. 2024. online ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0044-1790603</ArticleId><ArticleId IdType="pubmed">39348850</ArticleId></ArticleIdList></Reference><Reference><Citation>Hailemariam D., Lam T.H., Dervishi E., Zwierzchowski G., Wishart D.S., Ametaj B.N. Combination of mouse prion protein with detoxified lipopolysaccharide triggers colon genes related to inflammatory, antibacterial, and apoptotic responses. Res. Vet. Sci. 2022;144:98&#x2013;107. doi: 10.1016/j.rvsc.2022.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rvsc.2022.01.016</ArticleId><ArticleId IdType="pubmed">35093722</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleem F., Bjorndahl T.C., Ladner C.L., Perez-Pineiro R., Ametaj B.N., Wishart D.S. Lipopolysaccharide induced conversion of recombinant prion protein. Prion. 2014;8:221&#x2013;232. doi: 10.4161/pri.28939.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.28939</ArticleId><ArticleId IdType="pmc">PMC4189894</ArticleId><ArticleId IdType="pubmed">24819168</ArticleId></ArticleIdList></Reference><Reference><Citation>Zwierzchowski G., Hailemariam D., Dunn S., Wishart D., Ametaj B. Subcutaneously administered LPS-converted recombinant mouse prion protein alone or in combination with LPS modulates the content of prion-related proteins in the brain of FVB/N mice. Prion. 2015;9:S24&#x2013;S25.</Citation></Reference><Reference><Citation>Okuducu Y.K., Boribong B., Ellett F., Hajizadeh S., VanElzakker M., Haas W., Pillai S., Fasano A., Irimia D., Yonker L. Evidence Circulating Microclots and Activated Platelets Contribute to Hyperinflammation within Pediatric Post Acute Sequala of COVID. Am. J. Respir. Crit. Care Med. 2024;209:A2247.</Citation></Reference><Reference><Citation>Protopopova A.D., Barinov N.A., Zavyalova E.G., Kopylov A.M., Sergienko V.I., Klinov D.V. Visualization of fibrinogen alphaC regions and their arrangement during fibrin network formation by high-resolution AFM. J. Thromb. Haemost. 2015;13:570&#x2013;579. doi: 10.1111/jth.12785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12785</ArticleId><ArticleId IdType="pubmed">25393591</ArticleId></ArticleIdList></Reference><Reference><Citation>Biyani R., Hirata K., Oqmhula K., Yurtsever A., Hongo K., Maezono R., Takagi M., Fukuma T., Biyani M. Biophysical Properties of the Fibril Structure of the Toxic Conformer of Amyloid-beta42: Characterization by Atomic Force Microscopy in Liquid and Molecular Docking. ACS Appl. Mater. Interfaces. 2023;15:27789&#x2013;27800. doi: 10.1021/acsami.3c06460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsami.3c06460</ArticleId><ArticleId IdType="pubmed">37261999</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>